画像から学ぶびまん性肺疾患

出版社: 克誠堂出版
著者:
発行日: 2018-04-03
分野: 臨床医学:内科  >  呼吸器一般
ISBN: 9784771904989
電子書籍版: 2018-04-03 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

10,450 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

10,450 円(税込)

商品紹介

画像診断が難しいとされるびまん性肺疾患。画像の特徴と疾患の成り立ちを詳しく解説する。あらゆる疾患を網羅した本は、実は本書が初めて。納得の大ボリューム!

目次

  • Part 1 間質性肺炎の画像診断
     A 特発性間質性肺炎
     B 二次性間質性肺炎
     C 間質性肺炎の合併症

    Part 2 間質性肺炎以外の画像診断
     D 肉芽腫性疾患
     E アレルギー性疾患
     F 腫瘍性疾患ないし腫瘍類似性疾患
     G 嚢胞性疾患
     H 蓄積性疾患
     I 血管炎
     J 感染症・急性肺障害
     K 気道病変
     L 薬剤性肺障害

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

Part 1 間質性肺炎の画像診断

P.11 掲載の参考文献
1) Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011 ; 183 : 788-824.
2) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
3) Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005 ; 171 : 1040-7.
4) Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010 ; 35 : 821-9.
5) King TE Jr, Brown KK, Raghu G, et al. BUILD-3 : a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011 ; 184 : 92-9.
6) Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY) : two randomised trials. Lancet 2011 ; 377 : 1760-9.
7) Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis : a Fleischner Society White Paper. Lancet Respir Med 2017 : doi : 10.1016/s2213-2600 (17) 30433-2 [Ebub ahead of print]
8) Travis WD, Hunninghake G, King TE Jr, et al. Idiopathic nonspecific interstitial pneumonia : report of an American Thoracic Society project. Am J Respir Crit Care Med 2008 ; 177 : 1338-47.
9) Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement : interstitial pneumonia with autoimmune features. Eur Respir J 2015 ; 46 : 976-87.
10) 武村民子. 慢性線維化性間質性肺炎と蜂巣肺の病理. 酒井文和, 上甲 剛, 野間恵之, 編. 特発性肺線維症の画像診断. 東京 : メディカルサイエンスインターナショナル, 2015 : 25-56.
11) Sumikawa H, Johkoh T, Colby TV, et al. Computed tomography findings in pathological usual interstitial pneumonia : relationship to survival. Am J Respir Crit Care Med 2008 ; 177 : 433-9.
12) Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society : glossary of terms for thoracic imaging. Radiology 2008 ; 246 : 697-722.
13) Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003 ; 124 : 1215-23.
14) Johkoh T, Muller NL, Cartier Y, et al. Idiopathic interstitial pneumonias : diagnostic accuracy of thinsection CT in 129 patients. Radiology 1999 ; 211 : 555-60.
15) Akira M, Inoue Y, Kitaichi M, et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema : thin-section CT findings. Radiology 2009 ; 251 : 271-9.
16) Ando Y, Okada F, Matsumoto S, et al. Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) -related disease. CT findings in 51 patients. J Comput Assist Tomogr 2004 ; 28 : 710-6.
17) Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002 ; 19 : 275-83.
18) Iwasawa T, Takemura T, Okudera K, et al. The importance of subpleural fibrosis in the prognosis of patients with idiopathic interstitial pneumonias. Eur J Radiol 2017 ; 90 : 106-13
19) Iwasawa T, Iwao Y, Takemura T, et al. Extraction of the subpleural lung region from computed tomography images to detect interstitial lung disease. Jpn J Radiol 2017 ; doi : 10.1007/s11604-017-0683-2. [Epub ahead of print]
20) Kawabata Y, Hoshi E, Murai K, et al. Smokingrelated changes in the background lung of specimens resected for lung cancer : a semiquantitative study with correlation to postoperative course. Histopathology 2008 ; 53 : 707-14.
21) Katzenstein AL. Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod Pathol 2012 ; 25 : S68-78.
22) Watanabe Y, Kawabata Y, Kanauchi T, et al. Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis. Eur J Radiol 2015 ; 84 : 986-92.
23) Omori T, Tajiri M, Baba T, et al. Pulmonary resection for lung cancer in patients with idiopathic interstitial pneumonia. Ann Thorac Surg 2015 ; 100 : 954-60.
24) Sakai S, Ono M, Nishio T, et al. Lung cancer associated with diffuse pulmonary fibrosis : CT-pathologic correlation. J Thorac Imaging 2003 ; 18 : 67-71.
25) Akira M, Kozuka T, Yamamoto S, et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008 ; 178 : 372-8.
26) Sprunger DB, Olson AL, Huie TJ, et al. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. Eur Respir J 2012 ; 39 : 125-32.
27) Iwasawa T, Kato S, Ogura T, et al. Low-normal lung volume correlates with pulmonary hypertension in fibrotic idiopathic interstitial pneumonia : computeraided 3D quantitative analysis of chest CT. AJR Am J Roentgenol 2014 ; 203 : W166-73.
28) Kimura M, Taniguchi H, Kondoh Y, et al. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Respiration 2013 ; 85 : 456-63.
29) Kato S, Sekine A, Kusakawa Y, et al. Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease. J Cardiovasc Magn Reson 2015 ; 17 : 10.
P.18 掲載の参考文献
1) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002 ; 165 : 277-304.
2) Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994 ; 18 : 136-47.
3) Travis WD, Hunninghake G, King TE Jr., et al. Idiopathic nonspecific interstitial pneumonia : report of an American Thoracic Society project. Am J Respir Crit Care Med 2008 ; 177 : 1338-47.
4) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
5) Silva CIS, Muller NL, Hansell DM, et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis : changes in pattern and distribution of disease over time. Radiology 2008 ; 247 : 251-9.
6) Silva CIS, Muller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis : differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT1. Radiology 2008 ; 246 : 288-97.
7) Kim TS, Lee KS, Chung MP, et al. Nonspecific interstitial pneumonia with fibrosis : high-resolution CT and pathologic findings. AJR Am J Roentgenol 1998 ; 171 : 1645-50.
8) Silva CI, Muller NL, Fujimoto K, et al. Acute exacerbation of chronic interstitial pneumonia : high-resolution computed tomography and pathologic findings. J Thorac Imaging 2007 ; 22 : 221-9.
9) Hartman TE, Swensen SJ, Hansell DM, et al. Nonspecific interstitial pneumonia : variable appearance at high-resolution chest CT. Radiology 2000 ; 217 : 701-5.
10) Johkoh T, Muller NL, Colby TV, et al. Nonspecific interstitial pneumonia : correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002 ; 225 : 199-204.
11) Akira M, Inoue Y, Kitaichi M, et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema : thin-section CT findings. Radiology 2009 ; 251 : 271-9.
12) Sumikawa H, Johkoh T, Ichikado K, et al. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia : analysis of CT appearance in 92 patients. Radiology 2006 ; 241 : 258-66.
13) Sumikawa H, Johkoh T, Fujimoto K, et al. Pathologically proved nonspecific interstitial pneumonia : CT pattern analysis as compared with usual interstitial pneumonia CT pattern. Radiology 2014 ; 272 : 549-56.
14) Akira M, Inoue G, Yamamoto S, et al. Non-specific interstitial pneumonia : findings on sequential CT scans of nine patients. Thorax 2000 ; 55 : 854-9.
15) Park IN, Kim DS, Shim TS, et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007 ; 132 : 214-20.
16) Sverzellati N, Lynch DA, Hansell DM, et al. American Thoracic Society-European Respiratory Society Classification of the idiopathic interstitial pneumonias : advances in knowledge since 2002. Radiographics 2015 ; 35 : 1849-71.
17) Watanabe K, Handa T, Tanizawa K, et al. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med 2011 ; 105 : 1238-47.
18) Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia. Am J Respir Crit Care Med 2007 ; 176 : 691-7.
19) Fischer A, West SG, Swigris JJ, et al. Connective tissue disease-associated interstitial lung disease : a call for clarification. Chest 2010 ; 138 : 251-6.
20) Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease : a distinct entity. Chest 2011 ; 140 : 1292-9.
21) Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement : interstitial pneumonia with autoimmune features. Eur Respir J 2015 ; 46 : 976-87.
P.26 掲載の参考文献
1) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
2) Doan ML, Guillerman RP, Fan LL, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008 ; 63 : 366-73.
3) Bullard JE, Wert SE, Nogee LM, et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005 ; 172 : 1026-31.
4) Tazelaar HD, Wright JL, Churg A. Desquamative interstitial pneumonia. Histopathology 2011 ; 58 : 509-16.
5) Ryu JH, Myers JL, Decker PA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitisassociated interstitial lung disease. Chest 2005 ; 127 : 178-84.
6) Webb WR, Muller NL, Naidich DP. High resolution CT of the lung, 4th ed. Philadelphia : Lippincott Williams & Wilkins, 2012.
7) Akira M, Yamamoto S, Ueda E, et al. Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997 ; 52 : 333-7.
8) Hartman TE, Primack SL, Muller NL, et al. Desquamative interstitial pneumonia : thin-section CT findings in 22 patients. Radiology 1993 ; 187 : 787-90.
9) Koyama M, Johkoh T, Honda O, et al. Chronic cystic lung disease : diagnostic accuracy of high-resolution CT in 92 patients. AJR Am J Roentgenol 2003 ; 180 : 827-35.
10) Nakazawa A, Hagiwara E, Ogura T, et al. Surgically proven desquamative interstitial pneumonia induced by waterproofing spray. Intern Med 2014 ; 53 : 2107-10.
11) Yamakawa H, Suido Y, Sadoyama S, et al. Desquamative interstitial pneumonia with IgG4-related lung disease. Intern Med 2017 ; 56 : 1553-6.
12) Kawabata Y, Takemura T, Desquamative Interstitial Pneumonia Study Group. Desquamative interstitial pneumonia may progress to lung fibrosis as characterized radiologically. Respirology 2012 ; 17 : 1214-21.
13) Fraig M, Shreesha U, Katzenstein AL, et al. Respiratory bronchiolitis : a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002 ; 26 : 647-53.
P.33 掲載の参考文献
1) American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002 ; 165 : 277-304.
2) An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
3) Kim DS, Collard HR, King TE Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006 ; 3 : 285-92.
4) Poletti V, Cazzato S, Minicuci N, et al. The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J 1996 ; 9 : 2513-6.
5) Cordier J, Cottin V. Organizing pneumonia. In : Albert RK, Spiro SG, Jett JR, editors. Clinical respiratory medicine, 3rd ed. Philadelphia : Elsevier, 2008 : 689-793.
6) 大成洋二郎, 横山章仁, 河野修興. 間質性肺炎と血清マーカー. 呼吸 2005 ; 24 : 308-13.
7) Costabel U, Tescheler H, Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP) : the cytological and immunocytological profile of bronchioalveolar lavage. Eur Respir J 1992 ; 5 : 791-7.
8) Cohen AJ, King TE, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Cirt Care Med 1994 ; 149 : 1670-5.
9) Yousem SA, Lohr RH, Colby TV. Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome : pathologic predictors. Mod Pathol 1997 ; 10 : 864-71.
10) Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, et al. Cryptogenic and secondary organizing pneumonia : clinical presentation, radiographic findings, treatment response, and prognosis. Chest 2011 ; 139 : 893-900.
11) Beasley MB. Acute lung injury. In : Tomashefski JF, editor. Dail and Hammar's pulmonary pathology. New York : Springer, 2008 : 64-83.
12) Jeong YJ, Kim KI, Seo IJ, et al. Eosinophilic lung diseases : a clinical, radiologic, and pathologic overview. Radiographics 2007 ; 27 : 617-37.
13) Lee KS, Kullnig P, Hartman TE, et al. Cryptogenic organizing pneumonia : CT findings in 43 patients. AJR Am J Roentgenol 1994 ; 162 : 543-6.
14) Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia : diagnostic implications. AJR Am J Roentgenol 2003 ; 180 : 1251-4.
15) Ujita M, Renzoni EA, Veeraraghavan S, et al. Organizing pneumonia : perilobular pattern at thin-section CT. Radiology 2004 ; 232 : 757-61.
16) Lee JW, Lee KS, Lee HY, et al. Cryptogenic organizing pneumonia : serial high-resolution CT findings in 22 patients. AJR Am J Roentgenol 2010 ; 195 : 916-22.
17) Oikonomou A, Hansell DM. Organizing pneumonia : the many morphological faces. Eur Radiol 2002 ; 12 : 1486-96.
18) Lynch DA, Travis WD, Muller NL, et al. Idiopathic interstitial pneumonias : CT features. Radiology 2005 ; 236 : 10-21.
19) Akira M, Yamamoto S, Sakatani M. Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR Am J Roentgenol 1998 ; 170 : 291-5.
20) Ikezoe J, Johkoh T, Kohno N, et al. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging 1996 ; 11 : 250-9.
21) Muller NL, Staples CA, Miller RR. Bronchiolitis obliterans organizing pneumonia : CT features in 14 patients. AJR Am J Roentgenol 1990 ; 154 : 983-7.
22) Muller NL, Miller RR. Diseases of the bronchioles : CT and histopathologic findings. Radiology 1995 ; 196 : 3-12.
23) Voloudaki AE, Bouros DE, Froudarakis ME, et al. Crescentic and ring-shaped opacities. CT features in two cases of bronchiolitis obliterans organizing pneumonia (BOOP). Acta Radiol 1996 ; 37 : 889-92.
24) Marchiori E, Zanetti G, Meirelles GS, et al. The reversed halo sign on high-resolution CT in infectious and noninfectious pulmonary diseases. AJR Am J Roentgenol 2011 ; 197 : W69-75.
25) Johkoh T, Itoh H, Muller NL, et al. Crazy-paving appearance at thin-section CT : spectrum of disease and pathologic findings. Radiology 1999 ; 211 : 155-60.
26) Fischer A, Swigris JJ, du Bois RM, et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009 ; 103 : 1719-24.
P.40 掲載の参考文献
1) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
2) Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998 ; 157 : 199-203.
3) Quefatieh A, Stone CH, DiGiovine B, et al. Low hospital mortality in patients with acute interstitial pneumonia. Chest 2003 ; 124 : 554-9.
4) Suh GY, Kang EH, Chung MP, et al. Early intervention can improve clinical outcome of acute interstitial pneumonia. Chest 2006 ; 129 : 753-61.
5) 日本呼吸器学会ARDSガイドライン作成委員会, 編. ALI/ARDS診療のためのガイドライン. 東京 : 秀潤社, 2005.
6) Primack SL, Hartman TE, Ikezoe J, et al. Acute interstitial pneumonia : radiographic and CT findings in nine patients. Radiology 1993 ; 188 : 817-20.
7) Ichikado K, Johkoh T, Ikezoe J, et al. Acute interstitial pneumonia : high-resolution CT findings correlated with pathology. Am J Roentgenol 1997 ; 168 : 333-8.
8) Johkoh T, Muller NL, Taniguchi H, et al. Acute interstitial pneumonia : thin-section CT findings in 36 patients. Radiology l999 ; 211 : 859-63.
9) Ichikado K, Suga M, Muller NL, et al. Acute interstitial pneumonia : comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 2002 ; 165 : 1551-6.
10) Silva CI, Muller NL, Fujimoto K, et al. Acute exacerbation of chronic interstitial pneumonia : high-resolution computed tomography and pathologic findings. J Thorac Imaging 2007 ; 22 : 221-9.
11) Akira M, Kozuka T, Yamamoto S, et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008 ; 178 : 372-8.
12) Connors GR, Christopher-Stine L, Oddis CV, et al. Interstitial lung disease associated with the idiopathic inflammatory myopathies : what progress has been made in the past 35 years? Chest 2010 ; 138 : 1464-74.
13) 野間恵之, 崔乗哲, 前谷洋爾, ほか. 皮膚筋炎/多発性筋炎に伴う間質性肺炎とUIPの比較 : HRCT像を中心に. 臨放 1997 ; 42 : 105-10.
14) Goodman LR, Fumagalli R, Tagliabue P, et al. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes : CT, clinical, and functional correlations. Radiology 1999 ; 213 : 545-52.
15) Tomiyama N, Muller NL, Johkoh T, et al. Acute respiratory distress syndrome and acute interstitial pneumonia : comparison of thin-section CT findings. J Comput Assist Tomogr 2001 ; 25 : 28-33.
16) 日本呼吸器学会薬剤性肺障害の診断・治療の手引き作成委員会, 編. 薬剤性肺障害の診断・治療の手引き. 東京 : メディカルレビュー社, 2012.
17) Castaner E, Alguersuari A, Gallardo X, et al. When to suspect pulmonary vasculitis : radiologic and clinical clues. Radiographics 2010 ; 30 : 33-53.
18) Beasley MB, Franks TJ, Galvin JR, et al. Acute fibrinous and organizing pneumonia : histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002 ; 26 : 1064-70.
19) 上甲剛. ATS/ERS 2013 IIPs分類と今後の課題 : 画像上の要点と今後の課題. 日胸 2014 ; 73 : 1288-94.
P.48 掲載の参考文献
1) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
2) American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002 ; 165 : 277-304.
3) 渡辺憲太朗. IPPFEの臨床と病理・病態. 日胸 2014 ; 73 : 1307-19.
4) Watanabe K, Nagata N, Kitasato Y, et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig 2012 ; 50 : 88-97.
5) Oda T, Ogura T, Kitamura H, et al. Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis. Chest 2014 ; 146 : 1248-55.
6) 網谷良一, 新実彰男, 久世文幸. 特発性上葉限局型肺線維症. 呼吸 1992 ; 11 : 693-9.
7) Frankel SK, Cool CD, Lynch DA, et al. Idiopathic pleuroparenchymal fibroelastosis : description of a novel clinicopathologic entity. Chest 2004 ; 126 : 2007-13.
8) Becker CD, Gil J, Padilla ML. Idiopathic pleuroparenchymal fibroelastosis : an unrecognized or misdiagnosed entity? Mod Pathol 2008 ; 21 : 784-7.
9) Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis : a spectrum of histopathological and imaging phenotypes. Eur Respir J 2012 ; 40 : 377-85.
10) von der Thusen JH, Hansell DM, Tominaga M, et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol 2011 ; 24 : 1633-9.
11) Takeuchi Y, Miyagawa-Hayashino A, Chen F, et al. Pleuroparenchymal fibroelastosis and non-specific interstitial pneumonia : frequent pulmonary sequelae of haematopoietic stem cell transplantation. Histopathology 2015 ; 66 : 536-44.
12) Ofek E, Sato M, Saito T, et al. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Mod Pathol 2013 ; 26 : 350-6.
13) 渡辺憲太朗. 二次性上葉肺線維症 : 肺MAC症, 潰瘍性大腸炎, 食道癌照射後, 肺移植後. 日サ会誌 2013 ; 33 : 57-60.
P.55 掲載の参考文献
1) Remy-Jardin M, Remy J, Cortet B, et al. Lung changes in rheumatoid arthritis : CT findings. Radiology 1994 ; 193 : 375-82.
2) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002 ; 165 : 277-304.
3) Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005 ; 127 : 2019-27.
4) Kim EJ, Collard HR, King TE Jr. Rheumatoid arthritis-associated interstitial lung disease : the relevance of histopathologic and radiographic pattern. Chest 2009 ; 136 : 1397-405.
5) Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases : CT findings. Radiology 2004 ; 232 : 81-91.
6) Yoshinouchi T, Ohtsuki Y, Fujita J, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 2005 ; 26 : 121-5.
7) Johkoh T, Muller NL, Colby TV, et al. Nonspecific interstitial pneumonia : correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002 ; 225 : 199-204.
8) Katzenstein ALA. Systemic diseases involving the lung. In : Katzenstein ALA, editor. Katzenstein and Askin's surgical pathology of non-neoplastic lung disease, 4th ed. Philadelphia : Elsevier Saunders, 2006 : 187-215.
9) Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia : idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007 ; 175 : 705-11.
10) Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease : CT patterns and their courses. J Comput Assist Tomogr 1999 ; 23 : 941-8.
11) Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia : diagnostic implications. AJR Am J Roentgenol 2003 ; 180 : 1251-4.
12) D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969 ; 46 : 428-40.
13) Kim DS, Yoo B, Lee JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002 ; 19 : 121-7.
14) Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002 ; 165 : 1581-6.
15) Nicholson AG, Colby TV, Wells AU. Histopathological approach to patterns of interstitial pneumonia in patient with connective tissue disorders. Sarcoidosis Vasc Diffuse Lung Dis 2002 ; 19 : 10-7.
16) Remy-Jardin M, Remy J, Wallaert B, et al. Pulmonary involvement in progressive systemic sclerosis : sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 1993 ; 188 : 499-506.
17) Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis : comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004 ; 232 : 560-7.
19) Shah RM, Jimenez S, Wechsler R. Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis. J Thorac Imaging 2007 ; 22 : 120-4.
20) Bhalla M, Silver RM, Shepard JA, et al. Chest CT in patients with scleroderma : prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol 1993 ; 161 : 269-72.
21) Koyama M, Johkoh T, Honda O, et al. Pulmonary involvement in primary Sjogren's syndrome : spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging 2001 ; 16 : 290-6.
22) Johkoh T, Muller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia : thin-section CT findings in 22 patients. Radiology 1999 ; 212 : 567-72.
23) Egashira R, Kondo T, Hirai T, et al. CT findings of thoracic manifestations of primary Sjogren syndrome : radiologic-pathologic correlation. Radiographics 2013 ; 33 : 1933-49.
24) Franquet T, Gimenez A, Monill JM, et al. Primary Sjogren's syndrome and associated lung disease : CT findings in 50 patients. AJR Am J Roentgenol 1997 ; 169 : 655-8.
25) Bodolay E, Szekanecz Z, Devenyi K, et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) 2005 ; 44 : 656-61.
26) Kozuka T, Johkoh T, Honda O, et al. Pulmonary involvement in mixed connective tissue disease : highresolution CT findings in 41 patients. J Thorac Imaging 2001 ; 16 : 94-8.
27) Saito Y, Terada M, Takada T, et al. Pulmonary involvement in mixed connective tissue disease : comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002 ; 26 : 349-57.
P.62 掲載の参考文献
1) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
2) 日本呼吸器学会ARDSガイドライン作成委員会, 編. ALI/ARDS診療のためのガイドライン (第2版). 東京 : 日本呼吸器学会, 2010.
3) Tanaka N, Newell JD, Brown KK, et al. Collagen vascular disease-related lung disease : high-resolution computed tomography findings based on the pathologic classification. J Comput Assist Tomogr 2004 ; 28 : 351-60.
4) Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS. Acute exacerbations of interstitial lung diseases. Curr Opin Pulm Med 2010 ; 16 : 480-6.
5) Muller NL, Silva CIS. Acute interstitial pneumonia. In : Imaging of the Chest. Philadelphia : Saunders, 2008 : 663-7.
6) Swigris JJ, Brown KK. Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fibrosis. Semin Respir Crit Care Med 2006 ; 27 : 659-67.
7) Johkoh T, Muller NL, Taniguchi H, et al. Acute interstitial pneumonia : thin-section CT findings in 36 patients. Radiology 1999 ; 211 : 859-63.
8) Ichikado K, Johkoh T, Ikezoe J, et al. Acute interstitial pneumonia : high-resolution CT findings correlated with pathology. AJR Am J Roentgenol 1997 ; 168 : 333-8.
9) Muller NL, Silva CIS. Cryptogenic organizing pneumonia (bronchiolitis obliterans organizing pneumonia). In : Imaging of the Chest. Philadelphia : Saunders, 2008 : 655-62.
10) Akira M, Yamamoto S, Sakatani M. Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR Am J Roentgenol 1998 ; 170 : 291-5.
11) Roberton BJ, Hansell DM. Organizing pneumonia : a kaleidoscope of concepts and morphologies. Eur Radiol 2011 ; 21 : 2244-54.
12) Ujita M, Renzoni EA, Veeraraghavan S, et al. Organizing pneumonia : perilobular pattern at thin-section CT. Radiology 2004 ; 232 : 757-61.
13) Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia : diagnostic implications. AJR Am J Roentgenol 2003 ; 180 : 1251-4.
14) Zompatori M, Poletti V, Battista G, et al. Bronchiolitis obliterans with organizing pneumonia (BOOP), presenting as a ring-shaped opacity at HRCT (the atoll sign). A case report. Radiol Med 1999 ; 97 : 308-10.
15) Beardsley B, Rassl D. Fibrosing organising pneumonia. J Clin Pathol 2013 ; 66 : 875-81.
16) Kligerman SJ, Franks TJ, Galvin JR. From the radiologic pathology archives : organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics 2013 ; 33 : 1951-75.
17) Todd NW, Marciniak ET, Sachdeva A, et al. Organizing pneumonia/non-specific interstitial pneumonia overlap is associated with unfavorable lung disease progression. Respir Med 2015 ; 109 : 1460-8.
18) Lee JW, Lee KS, Lee HY, et al. Cryptogenic organizing pneumonia : serial high-resolution CT findings in 22 patients. AJR Am J Roentgenol 2010 ; 195 : 916-22.
19) 河端美則, 海野剛, 谷口博之, ほか. 亜急性に経過する間質性肺炎の臨床病理像. 日胸疾患会誌 1995 ; 33 : 705-14.
P.73 掲載の参考文献
1) Solomon JJ, Ryu JH, Tazelaar HD, et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med 2013 ; 107 : 1247-52.
2) Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis : comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004 ; 232 : 560-7.
3) Arakawa H, Yamada H, Kurihara Y, et al. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis : serial high-resolution CT findings and functional correlation. Chest 2003 ; 123 : 1096-103.
4) 福村敦, 小川法良, 下山久美子, ほか. シェーグレン症候群の経過中に皮膚筋炎を合併し急速進行性間質性肺炎にて死亡した1症例. リウマチ 2001 ; 41 : 37-43.
5) Tsujimura S, Saito K, Nakayamada S, et al. Human urinary trypsin inhibitor bolus infusion improved severe interstitial pneumonia in mixed connective tissue disease. Mod Rheumatol 2005 ; 15 : 374-80.
6) Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia : lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007 ; 176 : 691-7.
7) Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement : interstitial pneumonia with autoimmune features. Eur Respir J 2015 ; 46 : 976-87.
8) Mejia M, Herrera-Bringas D, Perez-Roman DI, et al. Interstitial lung disease and myositis-specific and associated autoantibodies : clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF). Respir Med 2017 ; 123 : 79-86.
9) Mosca M, Tavoni A, Neri R, et al. Undifferentiated connective tissue diseases : the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus 1998 ; 7 : 95-100.
10) Corte TJ, Copley SJ, Desai SR, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012 ; 39 : 661-8.
11) Fischer A, West SG, Swigris JJ, et al. Connective tissue disease-associated interstitial lung disease : a call for clarification. Chest 2010 ; 138 : 251-6.
12) Omote N, Taniguchi H, Kondoh Y, et al. Lung-dominant connective tissue disease : clinical, radiologic, and histologic features. Chest 2015 ; 148 : 1438-46.
13) Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease : a distinct entity. Chest 2011 ; 140 : 1292-9.
14) 藤本公則, 田中伴典, 福岡順也. 特発性間質性肺炎のABC-ATS/ERS特発性間質性肺炎の高分解能CT所見と病理組織所見. 高橋雅士, 編. 新胸部画像診断の勘ドコロ. 東京 : メジカルビュー社, 2014 : 201-36.
15) Plociniczak A, Gozdzik-Spychalska J, Batura-Gabryel HB. Interstitial pneumonia with autoimmune features (IPAF) and radiological findings suggestive of lymphocytic interstitial pneumonia (LIP) : case report. Adv Respir Med 2017 ; 85 : 46-50.
16) Oldham JM, Adegunsoye A, Valenzi E, et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 2016 ; 47 : 1767-75.
17) Chung JH, Montner SM, Adegunsoye A, et al. CT findings, radiologic-pathologic correlation, and imaging predictors of survival for patients with interstitial pneumonia with autoimmune features. AJR Am J Roentgenol 2017 ; 208 : 1229-36.
18) 藤本公則. 二次性UIPの画像診断. 1) 膠原病とその関連疾患. 酒井文和, 上甲 剛, 野間恵之, 編. 特発性肺線維症の画像診断. 東京 : メディカル・サイエンス・インターナショナル, 2015 : 163-82.
P.81 掲載の参考文献
1) Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema : a distinct underrecognised entity. Eur Respir J 2005 ; 26 : 586-93.
2) Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema : the value of high resolution computed tomography in assessment. Respir Med 1990 ; 84 : 365-9.
3) Hiwatari N, Shimura S, Takishima T. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration 1993 ; 60 : 354-8.
4) Doherty MJ, Pearson MG, O'Grady EA, et al. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997 ; 52 : 998-1002.
5) Grubstein A, Bendayan D, Schactman I, et al. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers : report of eight cases and review of the literature. Respir Med 2005 ; 99 : 948-54.
6) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
7) Lee G, Kim KU, Lee JW, et al. Serial changes and prognostic implications of CT findings in combined pulmonary fibrosis and emphysema : comparison with fibrotic idiopathic interstitial pneumonias alone. Acta Radiol 2017 ; 58 : 550-7.
8) Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010 ; 15 : 265-71.
9) Yoshida R, Arakawa H, Kaji Y. Lung cancer in chronic interstitial pneumonia : early manifestation from serial CT observations. AJR Am J Roentgenol 2012 ; 199 : 85-90.
10) Sugino K, Ishida F, Kikuchi N, et al. Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone. Respirology 2014 ; 19 : 239-45.
11) Kishaba T, Shimaoka Y, Fukuyama H, et al. A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema. BMJ Open 2012 ; 2 : pii : e000988.
12) Kurashima K, Takayanagi N, Tsuchiya N, et al. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 2010 ; 15 : 843-8.
14) Akira M, Inoue Y, Kitaichi M, et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema : thin-section CT findings. Radiology 2009 ; 251 : 271-9.
P.89 掲載の参考文献
1) Zenker FA. Ueber Staubinhalationskrankheiten der Lungen. Dtsch Arch Klin Med 1867 ; 2 : 116-72.
2) Bakan ND, Ozkan G, Camsari G, et al. Silicosis in denim sandblasters. Chest 2011 ; 140 : 1300-4.
3) 労災病院じん肺研究グループ, 編. よくわかる : じん肺健康診断. 東京 : 産業医学振興財団, 2017.
4) Macdonald G, Piggot AP, Gilder FW, et al. Two cases of acute silicosis. Lancet 1930 ; 216 : 846-8.
5) Buechner HA, Ansari A. Acute silico-proteinosis. A new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest 1969 ; 55 : 274-8.
6) Marchiori E, Souza CA, Barbassa TG, et al. Silicoproteinosis : high-resolution CT findings in 13 patients. Am J Roentgenol 2007 ; 189 : 1402-6.
7) Nagelschmidt G. The relation between lung dust and lung pathology in pneumoconiosis. Br J Ind Med 1960 ; 17 : 247-59.
8) Davis JM, Chapman J, Collings P, et al. Variations in the histological patterns of the lesions of coal workers' pneumoconiosis in Britain and their relationship to lung dust content. Am Rev Respir Dis 1983 ; 128 : 118-24.
9) Arakawa H, Honma K, Saito Y, et al. Pleural disease in silicosis : pleural thickening, effusion, and invagination. Radiology 2005 ; 236 : 685-93.
10) Gevenois PA, Pichot E, Dargent F, et al. Low grade coal worker's pneumoconiosis. Comparison of CT and chest radiography. Acta Radiol 1994 ; 35 : 351-6.
11) Begin R, Bergeron D, Samson L, et al. CT assessment of silicosis in exposed workers. AJR Am J Roentgenol 1987 ; 148 : 509-14.
12) Watanabe S, Shirakami A, Takeichi T, et al. Alterations in lymphocyte subsets and serum immunoglobulin levels in patients with silicosis. J Clin Lab Immunol 1987 ; 23 : 45-51.
13) Bruce T. Silicotuberculosis ; with special reference to Swedish conditions. Scand J Respir Dis Suppl 1968 ; 65 : 139-46.
14) Hnizdo E, Murray J. Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners. Occup Environ Med 1998 ; 55 : 496-502.
15) Snider DE Jr. The relationship between tuberculosis and silicosis. Am Rev Respir Dis 1978 ; 118 : 455-60.
16) World Health Organization, International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Geneva : IARC Press, 1997.
17) Katabami M, Dosaka-Akita H, Honma K, et al. Pneumoconiosis-related lung cancers : preferential occurrence from diffuse interstitial fibrosis-type pneumoconiosis. Am J Respir Crit Care Med 2000 ; 162 : 295-300.
18) Arakawa H, Shida H, Saito Y, et al. Pulmonary malignancy in silicosis : factors associated with radiographic detection. Eur J Radiol 2009 ; 69 : 80-6.
19) Tsuda T, Mino Y, Babazono A, et al. A case-control study of lung cancer in relation to silica exposure and silicosis in a rural area in Japan. Ann Epidemiol 2002 ; 12 : 288-94.
20) McConnochie K, Green FHY, Vallyathan V, et al. Interstitial fibrosis in coal workers : experience in Wales and West Virginia. Ann Occup Hyg 1988 ; 32 : S553-60.
21) Arakawa H, Johkoh T, Honma K, et al. Chronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis : its prevalence and comparison of CT findings with idiopathic pulmonary fibrosis. Chest 2007 ; 131 : 1870-6.
22) Brichet A, Tonnel AB, Brambilla E, et al. Chronic interstitial pneumonia with honeycombing in coal workers. Sarcoidosis Vasc Diffuse Lung Dis 2002 ; 19 : 211-9.
23) Honma K, Chiyotani K. Diffuse interstitial fibrosis in nonasbestos pneumoconiosis : a pathological study. Respiration 1993 ; 60 : 120-6.
P.96 掲載の参考文献
1) Wright JL, Churg A. Morphology of small-airway lesions in patients with asbestos exposure. Hum Pathol 1984 ; 15 : 68-74.
2) Dupre JS, Mustard JF, Uffen RJ, et al. Report of the Royal Commission on Matters of Health and Safety Arising from the Use of Asbestos in Ontario. Toronto : Ontario Ministry of the Attorney General, 1984.
3) Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities : diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 1982 ; 106 : 544-96.
4) Gefter WB, Conant EF. Issues and controversies in the plain-film diagnosis of asbestos-related disorders in the chest. J Thorac Imaging 1988 ; 3 : 11-28.
5) Akira M, Yamamoto S, Yokoyama K, et al. Asbestosis : high-resolution CT-pathologic correlation. Radiology 1990 ; 176 : 389-94.
6) Akira M, Yokoyama K, Yamamoto S, et al. Early asbestosis : evaluation with high-resolution CT. Radiology 1991 ; 178 : 409-16.
7) Bergin CJ, Castellino RA, Blank N, et al. Specificity of high-resolution CT findings in pulmonary asbestosis : do patients scanned for other indications have similar findings? AJR Am J Roentgenol 1994 ; 163 : 551-5.
8) Akira M, Yamamoto S, Inoue Y, et al. High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. AJR Am J Roentgenol 2003 ; 181 : 163-9.
9) Copley SJ, Wells AU, Sivakumaran P, et al. Asbestosis and idiopathic pulmonary fibrosis : comparison of thin-section CT features. Radiology 2003 ; 229 : 731-6.
10) Tossavainen A. Asbestos, asbestosis, and cancer : the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 1997 ; 23 : 311-6.
P.102 掲載の参考文献
1) Chiba S, Tsuchiya K, Akashi T, et al. Chronic hypersensitivity pneumonitis with a usual interstitial pneumonia-like pattern : correlation between histopathologic and clinical findings. Chest 2016 ; 149 : 1473-81.
2) Yoshizawa Y, Ohtani Y, Hayakawa H, et al. Chronic hypersensitivity pneumonitis in Japan : a nationwide epidemiologic survey. J Allergy Clin Immunol 1999 ; 103 : 315-20.
3) Ohtani Y, Saiki S, Sumi Y, et al. Clinical features of recurrent and insidious chronic bird fancier's lung. Ann Allergy Asthma Immunol 2003 ; 90 : 604-10.
4) Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
5) Johannson KA, Elicker BM, Vittinghoff E, et al. A diagnostic model for chronic hypersensitivity pneumonitis. Thorax 2016 ; 71 : 951-4.
6) Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis : insights in diagnosis and pathobiology. Am J Respir Crit Care Med 2012 ; 186 : 314-24.
7) Buschman DL, Gamsu G, Waldron JA Jr, et al. Chronic hypersensitivity pneumonitis : use of CT in diagnosis. AJR Am J Roentgenol 1992 ; 159 : 957-60.
8) Silva CIS, Churg A, Muller NL. Hypersensitivity pneumonitis : spectrum of high-resolution CT and pathologic findings. AJR Am J Roentgenol 2007 ; 188 : 334-44.
9) Churg A, Muller NL, Flint J, et al. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006 ; 30 : 201-8.
10) Tateishi T, Ohtani Y, Takemura T, et al. Serial high-resolution computed tomography findings of acute and chronic hypersensitivity pneumonitis induced by avian antigen. J Comput Assist Tomogr 2011 ; 35 : 272-9.
11) Silva CIS, Muller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis : differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008 ; 246 : 288-97.
12) Lynch DA, Newell JD, Logan PM, et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 1995 ; 165 : 807-11.
13) Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung : histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005 ; 60 : 665-71.
P.110 掲載の参考文献
1) Marshall RP, Puddicombe A, Cookson WOC, et al. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000 ; 55 : 143-6.
2) Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011 ; 364 : 1503-12.
3) Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005 ; 172 : 1146-52.
4) Setoguchi Y, Ikeda T, Fukuchi Y. Clinical features and genetic analysis of surfactant protein C in adultonset familial interstitial pneumonia. Respirology 2006 ; 11 : S41-5.
5) Nishiyama O, Taniguchi H, Kondoh Y, et al. Familial idiopathic pulmonary fibrosis : serial high-resolution computed tomography findings in 9 patients. J Comput Assist Tomogr 2004 ; 28 : 443-8.
6) Pradipkumar D, Gautham A, Gupta R, et al. Familial interstitial pulmonary fibrosis in two different families in India : a case series. Lung India 2017 ; 34 : 475-9.
7) Hermansky F, Pudluk P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone mallow : report of two cases with histochemical studies. Blood 1959 ; 14 : 162-9.
8) Witkop CJ, Almadovar C, Pineiro B, et al. Hermansky-Pudlak syndrome (HPS). An epidemiologic study. Ophthalmic Paediatr Genet 1990 ; 11 : 245-50.
9) Young LR, Gahl WA. Hermansky-Pudlak syndrome. In : McCormack FX, Panos RJ, Trapnell BC, editors. Molecular basis of pulmonary disease : insights from rare lung disorders. New York : Humana Press, 2010 : 189-207.
10) El-Chemaly S, Young LR. Hermansky-Pudlak syndrome. Clin Chest Med 2016 ; 37 : 505-11.
11) Avila NA, Brantly M, Premkumar A, et al. Hermansky-Pudlak syndrome : radiography and CT of chest compared with pulmonary function tests and genetic studies. AJR Am J Roentgenol 2002 ; 179 : 887-92.
12) Griese M. Pulmonary surfactant in health and human lung diseases : state of art. Eur Respir J 1999 ; 13 : 1455-76.
13) Nathan N, Giraud V, Picard C, et al. Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer. Hum Mol Genet 2016 ; 25 : 1457-67.
14) Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 2009 ; 84 : 52-9.
15) Nogee LM, Garnier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994 ; 93 : 1860-3.
16) Nogee LM, Dunbar AE 3rd, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001 ; 344 : 573-9.
17) Mulugeta S, Nureki S, Beers MF. Lost after translation : insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2015 ; 309 : L507-25.
18) Shulenin S, Nogee LM, Annilo T, et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004 ; 350 : 1296-303.
19) Doan ML, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008 ; 63 : 366-73.
20) Kitazawa H, Moriya K, Niizuma H, et al. Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations. Eur J Pediatr 2013 ; 172 : 953-7.
21) Armanios MY, Chen JJ, Cogan JP, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007 ; 356 : 1317-26.
22) Stuart BD, Choi J, Zaidi S, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet 2015 ; 47 : 512-7.
23) Cogan JD, Kropski JA, Zhao M, et al. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am J Respir Crit Care Med 2015 ; 191 : 646-55.
P.118 掲載の参考文献
1) Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011 ; 183 : 788-824.
2) Travis WD, Costabel U, Hansell DM ; ATS/ERS Committee on Idiopathic Interstitial Pneumonias, et al. An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013 ; 188 : 733-48.
3) Natsuizaka M, Chiba H, Kuronuma K, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 2014 ; 190 : 773-9.
4) Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis : analysis of clinical and pathologic findings in three cases. Chest 1993 ; 103 : 1808-12.
5) Collard HR, Moore BB, Flaherty KR ; Idiopathic pulmonary fibrosis clinical research investigators, et al. Acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007 ; 176 : 636-43.
6) 谷口博之, 近藤康博. 特発性肺線維症の急性増悪の新しい診断基準について. 厚生労働省特定疾患びまん性肺疾患調査研究班, 平成15年度研究報告書. 2004 : 114-9.
7) Fernandez Perez ER, Daniels CE, Schroeder DR, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis : a population-based study. Chest 2010 ; 137 : 129-37.
8) Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis : incidence, risk factors and outcome. Eur Respir J 2011 ; 37 : 356-63.
9) Kondoh Y, Taniguchi H, Katsuta T, et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2010 ; 27 : 103-10.
10) Hiwatani N, Shimura S, Takishima T, et al. Bronchoalveolar lavage as a possible cause of acute exacerbation in idiopathic pulmonary fibrosis patients. Tohoku J Exp Med 1994 ; 174 : 379-86.
11) Kondoh Y, Taniguchi H, Kitaichi M, et al. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med 2006 ; 100 : 1753-9.
12) Churg A, Muller NL, Silva CI, et al. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol 2007 ; 31 : 277-84.
13) 慢性の線維化をきたす間質性肺炎. 3. 急性増悪. 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会, 編. 特発性間質性肺炎診断と治療の手引き, 改訂第3版. 東京 : 南江堂, 2016 : 69-77.
14) Akira M, Kozuka T, Yamamoto S, et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008 ; 178 : 372-8.
15) Ichikado K, Suga M, Gushima Y, et al. Hyperoxiainduced diffuse alveolar damage in pigs : correlation between thin-section CT and histopathologic findings. Radiology 2000 ; 216 : 531-8.
16) Fujimoto K, Taniguchi H, Johkoh T, et al. Acute exacerbation of idiopathic pulmonary fibrosis : highresolution CT scores predict mortality. Eur Radiol 2012 ; 22 : 83-92.
17) 一門和哉. IPF/UIPの急性増悪のCT診断と病勢評価. 酒井文和, 上甲 剛, 野間惠之, 編. 特発性肺線維症の画像診断. 東京 : メディカル・サイエンス・インターナショナル, 2015 ; 227-40.
18) Miyazaki Y, Tateishi T, Akashi T, et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008 ; 134 : 1265-70.
19) Suda T, Kaida Y, Nakamura Y, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009 ; 103 : 846-53.
20) Sato S, Kuwana M, Fujita T, et al. Anti-CADM-140/MAD5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 2013 ; 23 : 496-502.
21) Franquet T, Gimenez A, Torrubia S, et al. Spontaneous pneumothorax and pneumomediastinum in IPF. Eur Radiol 2000 ; 10 : 108-13.
22) Picado C, Gomez de Almeida R, Xaubet A, et al. Spontaneous pneumothorax in cryptogenic fibrosing alveolitis. Respiration 1985 ; 48 : 77-80.
23) McLoud TC, Carrington CB, Gaensler EA. Diffuse infiltrative lung disease : a new scheme for description. Radiology 1983 ; 149 : 353-63.
24) Sakamoto N, Mukae H, Ishii H, et al. Spontaneous pneumothorax and pneumomediastinum in patients with idiopathic interstitial pneumonias. Acta Med Nagasaki 2006 ; 51 : 23-6.
25) 一色琢磨, 前村啓太, 竹島英之, ほか. 気胸を合併した間質性肺炎患者におけるステロイド剤の影響の検討. 日呼吸誌 2014 ; 3 : 207-13.
26) 草野英美子, 本間栄, 大津喜子, ほか. タルク未注入と胸腔胸下肺瘻閉鎖術が奏効した特発性肺線維症合併難治性気胸の1例. 日呼吸会誌 2005 ; 43 : 117-22.
27) 井上幸久, 古家正, 小野宏, ほか. 続発性気胸を合併した間質性肺炎の臨床的検討. 日呼吸会誌 2010 ; 48 : 724-8.
28) 長谷川英之, 大河内明子, 坂本洋, ほか. ステロイド治療と気胸. 日胸 1987 ; 46 : 660-8.
29) 高橋伸政, 星永進, 鍵山奈保, ほか. 気胸を合併した抗酸菌症症例の検討. 結核2012 ; 87 : 649-53.
30) Aktogu S, Yorgancioglu A, Cirak K, et al. Clinical spectrum of pulmonary and pleural tuberculosis : a report of 5,480 cases. Eur Respir J 1996 ; 9 : 2031-5.
31) Eastridge CE, Hamman JL. Pneumothorax complicated by chronic steroid treatment. Am J Surg 1973 ; 126 : 784-7.
32) Colombi D, Ehlers-Tenenbaum S, Palmowski K, et al. Spontaneous pneumomediastinum as a potential predictor of mortality in patients with idiopathic pulmonary fibrosis. Respiration 2016 ; 92 : 25-33.
33) Koga T, Fujikawa K, Horai Y, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford) 2012 ; 51 : 1278-84.
34) Masuda A, Tsushima T, Shizume K, et al. Recurrent pneumothoraces and mediastinal emphysema in systemic lupus erythematosus. J Rheumatol 1990 ; 17 : 544-8.
35) 里見和彦, 道端達也, 飯塚文朗, ほか. 皮膚筋炎関連肺線維症の経過中に縦隔気腫を繰り返した1例. 日呼吸会誌 1998 ; 36 : 984-8.
P.126 掲載の参考文献
1) Turner-Warwick M, Lebowitz M, Burrows B, et al. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980 ; 35 : 496-9.
2) Hubbard R, Venn A, Lewis S, et al. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000 ; 161 : 5-8.
3) Archontogeorgis K, Steiropoulos P, Tzouvelekis A, et al. Lung cancer and interstitial lung diseases : a systematic review. Pulm Med 2012 ; 2012 : 315918.
4) Park J, Kim DS, Shim TS, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001 ; 17 : 1216-9.
5) Samet JM. Does idiopathic pulmonary fibrosis increase lung cancer risk? Am J Respir Crit Care Med 2000 ; 161 : 1-2.
6) Koo HJ, Do KH, Lee JB, et al. Lung cancer in combined pulmonary fibrosis and emphysema : a systematic review and meta-analysis. PLoS One 2016 ; 11 : e0161437.
7) Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010 ; 15 : 265-71.
8) 坂東政司. IPF合併肺癌. 呼吸 2012 ; 31 : 738-46.
9) 石川暢久, 河野修興. 間質性肺炎と肺癌. 癌と化療 2010 ; 37 : 6-9.
10) Meyer EC, Liebow AA. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer 1965 ; 18 : 322-51.
11) Bremnes RM, Donnem T, Al-Saad S, et al. The role of tumor stroma in cancer progression and prognosis : emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol 2011 ; 6 : 209-17.
12) Puig M, Lugo R, Gabasa M, et al. Matrix stiffening and β1 integrin drive subtype-specific fibroblast accumulation in lung cancer. Mol Cancer Res 2015 ; 13 : 161-73.
13) Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993 ; 85 : 307-11.
14) 亀田智広, 土橋浩章. 関節リウマチと悪性腫瘍. 日臨 2016 ; 74 : 1017-21.
15) Dagan A, Segal G, Tiosano S, et al. Coexistent malignant conditions in rheumatoid arthritis : a population-based cross-sectional study. Int J Clin Pract 2017 ; 71 : doi : 10.1111/ijcp.12929.
16) Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus 2001 ; 10 : 394-400.
17) 武田誠司. 強皮症と悪性腫瘍. 日臨免誌 2004 : 27 : 389-96.
18) Dorph C, Lundberg IE. Idiopathic inflammatory myopathies-myositis. Best Pract Res Clin Rheumatol 2002 ; 16 : 817-32.
19) Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis : a population-based study. Lancet 2001 ; 357 : 96-100.
20) 河原正明. 腫瘍随伴症候群. 日本臨床腫瘍学会, 編. 新臨床腫瘍学 : がん薬物療法専門医のために. 東京 : 南江堂, 2006 : 664-9.
21) Sigurgeirsson B, Lindelof B, Edhag O, et al. Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 1992 ; 326 : 363-7.
22) Lazarus MN, Robinson D, Mak V, et al. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2006 ; 45 : 1012-5.
23) 宇治正人, 松下晴彦, 渡辺徹也, ほか. 肺腺癌を合併した原発性シェーグレン症候群の1例. 日呼吸会誌 2007 ; 45 : 409-12.
24) Maki D, Takahashi M, Murata K, et al. Computed tomography appearances of bronchogenic carcinoma associated with bullous lung disease. J Comput Assist Tomogr 2006 ; 30 : 447-52.
25) Lee HJ, Im JG, Ahn JM, et al. Lung cancer in patients with idiopathic pulmonary fibrosis : CT findings. J Comput Assist Tomogr 1996 ; 20 : 979-82.
26) Sakai S, Ono M, Nishio T, et al. Lung cancer associated with diffuse pulmonary fibrosis : CT-pathologic correlation. J Thorac Imaging 2003 ; 18 : 67-71.
27) Yoshida R, Arakawa H, Kaji Y. Lung cancer in chronic interstitial pneumonia : early manifestation from serial CT observations. AJR Am J Roentgenol 2012 ; 199 : 85-90.
28) Lyburn ID, Lowe JE, Wong WL. Idiopathic pulmonary fibrosis on F-18 FDG positron emission tomography. Clin Nucl Med 2005 ; 30 : 27.
29) Lillington GA. Management of solitary pulmonary nodules. Dis Mon 1991 ; 37 : 271-318.
30) Revel MP, Lefort C, Bissery A, et al. Pulmonary nodules : preliminary experience with three-dimensional evaluation. Radiology 2004 ; 23 : 459-66.
31) Tanimoto D, Ito K, Tamada T, et al. Serial 3-dimensional volumetric computed tomography evaluation of lung cancer growth rate in patients with chronic obstructive pulmonary disease findings. J Comput Assist Tomogr 2012 ; 36 : 181-6.
32) Oh SY, Kim MY, Kim JE, et al. Evolving early lung cancers detected during follow-up of idiopathic interstitial pneumonia : serial CT features. AJR Am J Roentgenol 2015 ; 204 : 1190-6.
33) 川村宏大, 一門和哉, 村中裕之, ほか. 間質性肺炎に対する少量ステロイド併用シクロスポリン治療中の悪性腫瘍発症例の検討. 日呼吸会誌 2010 ; 48 : 261-6.
34) Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis : involvement of vascular endothelial growth factor. Nat Med 2002 ; 8 : 128-35.
35) Sugiura H, Takeda A, Hoshi T, et al. Acute exacerbation of usual interstitial pneumonia after resection of lung cancer. Ann Thorac Surg 2012 ; 93 : 937-43.
36) 上甲剛. 薬剤性肺障害の画像診断の問題点 : イレッサ(R) コフォート内ケースコントロールstudyの結果より. 肺癌 2008 ; 48 : 727-31.
P.132 掲載の参考文献
1) Franquet T, Gimenez A, Torrubia S, et al. Spontaneous pneumothorax and pneumomediastinum in IPF. Eur Radiol 2000 ; 10 : 108-13.
2) Picado C, Gomez de Almedia R, Xaubet A, et al. Spontaneous pneumothorax in cryptogenic fibrosing alveolitis. Respiration 1985 ; 48 : 77-80.
3) 嶋元佳子, 尾崎吉郎, 安室秀樹, ほか. 縦隔気腫を合併した多発性筋炎・皮膚筋炎の3 症例. 日臨免誌 2008 ; 31 : 56-61.
4) 片岡秀之, 栗原正利. 間質性肺炎合併難治性気胸の治療. 胸部外科 2011 ; 64 : 311-5.
5) 田尻道彦. 特発性肺線維症における気胸. 呼吸器内科 2014 ; 26 : 176-80.
6) Pugliese SC, Poth JM, Fini MA, et al. The role of inflammation in hypoxic pulmonary hypertension : from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol 2015 ; 308 : L229-52.
7) Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension : The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) : Endorsed by : Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016 ; 37 : 67-119.
8) Yan W, Peng LY, Ban CJ, et al. Incidence and clinical characteristics of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chin Med J 2015 ; 128 : 896-901.
9) Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema : a distinct underrecognised entity. Eur Respir J 2005 ; 26 : 586-93.
11) Kwak N, Park CM, Lee J, et al. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med 2014 ; 108 : 524-30.
12) Sakai F, Tominaga J, Kaga A, et al. Imaging diagnosis of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema). Pulm Med 2012 ; 2012 : 816541.
13) Kim YS, Jin GY, Chae KJ, et al. Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema. Br J Radiol 2015 ; 88 : 20150545.
14) Choi SH, Lee HY, Lee KS, et al. The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE). PLoS One 2014 ; 9 : e107476.

Part 2 間質性肺炎以外の画像診断

P.144 掲載の参考文献
1) 日本サルコイドーシス/肉芽腫性疾患学会. サルコイドーシスの診断基準と診断の手引き-2015. 日本サルコイドーシス/肉芽腫性疾患学会ホームページ. URL : http://www.jssog.com/www/top/shindan/shindan2-1new.html
2) Statement on sarcoidosis. This Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999 ; 160 : 736-55.
3) Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int 2013 ; 2013 : 935289.
4) びまん性肺疾患に関する研究調査班 : サルコイドーシス (指定難病 84). 難病情報センターホームページ. URL : http://www.nanbyou.or.jp/entry/266 (情報更新日 2017/4/24)
5) Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997 ; 336 : 1224-34.
6) Baroni RH, Pedrosa I, Tavernaraki E, et al. Pancreatic sarcoidosis : MRI features. J Magn Reson Imaging 2004 ; 20 : 889-93.
7) Ardalan M, Esmaili H. Renal mass : a confusing feature of sarcoidosis. Ren Fail 2012 ; 34 : 661-3.
8) Afshar K, BoydKing A, Sharma OP, et al. Gastric sarcoidosis and review of the literature. J Natl Med Assoc 2010 ; 102 : 419-22.
10) Gotway MB, Reddy GP, Webb WR, et al. High-resolution CT of the lung : patterns of disease and differential diagnoses. Radiol Clin North Am 2005 ; 43 : 513-42.
11) Webb WR, Stein MG, Finkbeiner WE, et al. Normal and diseased isolated lungs : high-resolution CT. Radiology 1988 ; 166 : 81-7.
12) Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society : glossary of terms for thoracic imaging. Radiology 2008 ; 246 : 697-722.
13) Webb WR, Muller NL, Naidich DP. Sarcoidosis. In : High-resolution CT of the lung, 5th ed. Philadelphia : Wolters Kluwer Health, 2014 : 312-39.
14) Nakatsu M, Hatabu H, Morikawa K, et al. Large coalescent parenchymal nodules in pulmonary sarcoidosis : "sarcoid galaxy" sign. AJR Am J Roentgenol 2002 ; 178 : 1389-93.
15) Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006 ; 47 : 1571-6.
16) Braun JJ, Kessler R, Constantinesco A, et al. 18FFDG PET/CT in sarcoidosis management : review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008 ; 35 : 1537-43.
P.152 掲載の参考文献
1) Li CW, Li MH, Li JX, et al. Pulmonary Langerhans cell histiocytosis : analysis of 14 patients and literature review. J Thorac Dis 2016 ; 8 : 1283-9.
2) Tazi A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 2006 ; 27 : 1272-85.
3) Martin I, Ballester M, Ruiz Y, et al. Presentation of pulmonary Langerhans cell histiocytosis before the development of lung cysts. Respirol Case Rep 2013 ; 1 : 34-5.
4) Castoldi MC, Verrioli A, De Juli E, et al. Pulmonary Langerhans cell histiocytosis : the many faces of presentation at initial CT scan. Insights Imaging 2014 ; 5 : 483-92.
5) Kim HJ, Lee KS, Johkoh T, et al. Pulmonary Langerhans cell histiocytosis in adults : high-resolution CTpathology comparisons and evolutional changes at CT. Eur Radiol 2011 ; 21 : 1406-15.
6) Soler P, Bergeron A, Kambouchner M, et al. Is highresolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? Am J Respir Crit Care Med 2000 ; 162 : 264-70.
7) Brauner MW, Grenier P, Tijani K, et al. Pulmonary Langerhans cell histiocytosis : evolution of lesions on CT scans. Radiology 1997 ; 204 : 497-502.
8) Sundar KM, Gosselin MV, Chung HL, et al. Pulmonary Langerhans cell histiocytosis : emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 2003 ; 123 : 1673-83.
9) Arnaud L, Pierre I, Beigelman-Aubry C, et al. Pulmonary involvement in Erdheim-Chester disease : a single-center study of thirty-four patients and a review of the literature. Arthritis Rheum 2010 ; 62 : 3504-12.
10) Wittenberg KH, Swensen SJ, Myers JL. Pulmonary involvement with Erdheim-Chester disease : radiographic and CT findings. AJR Am J Roentgenol 2000 ; 174 : 1327-31.
11) Zaveri J, La Q, Yarmish G, et al. More than just Langerhans cell histiocytosis : a radiologic review of histiocytic disorders. Radiographics 2014 ; 34 : 2008-24.
12) Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996 ; 75 : 157-69.
13) Rush WL, Andriko JA, Galateau-Salle F, et al. Pulmonary pathology of Erdheim-Chester disease. Mod Pathol 2000 ; 13 : 747-54.
14) Antunes C, Graca B, Donato P. Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease : CT, MR and PET imaging findings. Insights Imaging 2014 ; 5 : 473-82.
15) Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy : a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 1972 ; 30 : 1174-88.
16) Shrestha B, Sekiguchi H, Colby TV, et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis : report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 2009 ; 33 : 1450-62.
17) de Jong WK, Kluin PM, Groen HM. Overlapping immunoglobulin G4-related disease and Rosai-Dorfman disease mimicking lung cancer. Eur Respir Rev 2012 ; 21 : 365-7.
18) El-Kersh K, Perez RL, Guardiola J. Pulmonary IgG4+ Rosai-Dorfman disease. BMJ Case Rep 2013 ; 2013 : pii : bcr2012008324.
19) Hasegawa M, Sakai F, Okabayashi A, et al. Rosai-Dorfman disease of the lung overlapping with IgG4-related disease : the difficulty in its differential diagnosis. Intern Med 2017 ; 56 : 937-41.
20) Roberts SS, Attanoos RL. IgG4+ Rosai-Dorfman disease of the lung. Histopathology 2010 ; 56 : 662-4.
21) Cartin-Ceba R, Golbin JM, Yi ES, et al. Intrathoracic manifestations of Rosai-Dorfman disease. Respir Med 2010 ; 104 : 1344-9.
22) Noguchi S, Yatera K, Shimajiri S, et al. Intrathoracic Rosai-Dorfman disease with spontaneous remission : a clinical report and a review of the literature. Tohoku J Exp Med 2012 ; 227 : 231-5.
23) Goupil de Bouille J, de Muret A, Diot E, et al. Pulmonary manifestations revealing Rosai-Dorfman disease. Sarcoidosis Vasc Diffuse Lung Dis 2015 ; 32 : 275-7.
P.160 掲載の参考文献
1) Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994 ; 150 : 1423-38.
2) Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases : diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000 ; 216 : 773-80.
3) Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 2005 ; 60 : 841-57.
4) Fox B, Seed WA. Chronic eosinophilic pneumonia. Thorax 1980 ; 35 : 570-80.
5) Mochimaru H, Kawamoto M, Fukuda Y, et al. Clinicopathological differences between acute and chronic eosinophilic pneumonia. Respirology 2005 ; 10 : 76-85.
6) Ebara H, Ikezoe J, Johkoh T, et al. Chronic eosinophilic pneumonia : evolution of chest radiograms and CT features. J Comput Assist Tomogr 1994 ; 18 : 737-44.
7) Chusid MJ, Dale DC, West BC, et al. The hypereosinophilic syndrome : analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975 ; 54 : 1-27.
8) Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012 ; 130 : 607-12.e9.
9) Kang EY, Shim JJ, Kim JS, et al. Pulmonary involvement of idiopathic hypereosinophilic syndrome : CT findings in five patients. J Comput Assist Tomogr 1997 ; 21 : 612-5.
10) Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990 ; 33 : 1094-100.
11) Choi YH, Im JG, Han BK, et al. Thoracic manifestation of Churg-Strauss syndrome : radiologic and clinical findings. Chest 2000 ; 117 : 117-24.
12) Worthy SA, Muller N, Hansell DM, et al. Churg-Strauss syndrome : the spectrum of pulmonary CT findings in 17 patients. AJR Am J Roentgenol 1998 ; 170 : 297-300.
13) Takayanagi N, Kanazawa M, Kawabata Y, et al. Chronic bronchiolitis with associated eosinophilic lung disease (eosinophilic bronchiolitis). Respiration 2001 ; 68 : 319-22.
14) 中込一之, 山口正雄, 島田浩太, ほか. 喘息様症状で発症し, びまん性小葉中心性陰影を呈した, 好酸球性細気管支炎・肺炎の1例. 日呼吸会誌 2003 ; 41 : 722-7.
15) 酒井啓行, 門脇麻衣子, 本定千知, ほか. 気管支喘息および慢性好酸球性肺炎を併発したと考えられた好酸球性細気管支炎の1例. アレルギー 2016 ; 65 : 134-7.
16) 永田忍彦, 原田進, 若松謙太郎, ほか. 気管支喘息の経過中に発症した慢性好酸球性細気管支炎の1例. 日呼吸会誌 2004 ; 42 : 767-71.
17) Cordier JF, Cottin V, Khouatra C, et al. Hypereosinophilic obliterative bronchiolitis : a distinct, unrecognised syndrome. Eur Respir J 2013 ; 41 : 1126-34.
18) Patterson R, Greenberger PA, Radin RC, et al. Allergic bronchopulmonary aspergillosis : staging as an aid to management. Ann Intern Med 1982 ; 96 : 286-91.
19) Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1984 ; 74 : 68-71.
20) Nguyen ET. The gloved finger sign. Radiology 2003 ; 227 : 453-4.
21) Martinez S, Heyneman LE, McAdams HP, et al. Mucoid impactions : finger-in-glove sign and other CT and radiographic features. Radiographics 2008 ; 28 : 1369-82.
22) Franquet T, Muller NL, Gimenez A, et al. Spectrum of pulmonary aspergillosis : histologic, clinical, and radiologic findings. Radiographics 2001 ; 21 : 825-37.
23) Ogawa H, Fujimura M, Takeuchi Y, et al. The definitive diagnostic process and successful treatment for ABPM caused by Schizophyllum commune : a report of two cases. Allergol Int 2012 ; 61 : 163-9.
24) Seki M, Ohno H, Gotoh K, et al. Allergic bronchopulmonary mycosis due to co-infection with Aspergillus fumigatus and Schizophyllum commune. IDCases 2014 ; 1 : 5-8.
25) Roig J, Romeu J, Riera C, et al. Acute eosinophilic pneumonia due to toxocariasis with bronchoalveolar lavage findings. Chest ; 102 : 294-6.
26) Sakai S, Shida Y, Takahashi N, et al. Pulmonary lesions associated with visceral larva migrans due to Ascaris suum or Toxocara canis : imaging of six cases. AJR Am J Roentgenol 2006 ; 186 : 1697-702.
27) Lee HK, Jin SL, Lee HP, et al. Loffler's syndrome associated with Clonorchis sinensis infestation. Korean J Intern Med 2003 ; 18 : 255-9.
28) Souza CA, Muller NL, Johkoh T, et al. Druginduced eosinophilic pneumonia : high-resolution CT findings in 14 patients. AJR Am J Roentgenol 2006 ; 186 : 368-73.
29) Hayes D Jr, Anstead MI, Kuhn RJ. Eosinophilic pneumonia induced by daptomycin. J Infect 2007 ; 54 : e211-3.
P.167 掲載の参考文献
1) Lacasse Y, Selman M, Costabel U, et al. Classification of hypersensitivity pneumonitis : a hypothesis. Int Arch Allergy Immunol 2009 ; 149 : 161-6.
2) 稲瀬直彦. 過敏性肺炎の診断と治療. 日内会誌 2014 ; 103 : 2269-74.
3) 日本呼吸器学会ホームページ. URL : http://www.jrs.or.jp/
4) Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis : current concepts and future questions. J Allergy Clin Immunol 2001 ; 108 : 661-70.
5) 大谷義夫, 稲瀬直彦, 吉澤靖之. 肉芽腫性肺疾患 (DATAで読み解く内科疾患). 綜合臨牀 2007 ; 56 : 1012-25.
6) 審良正則. 第4章 びまん性肺疾患, それに準じるもの : 過敏性肺炎. 高橋雅士, 上甲剛, 高橋康二, ほか, 編. 胸部画像診断スタンダード. 東京 : メディカル・サイエンス・インターナショナル, 2013 : 160-1.
7) 野間惠之. III-7章 びまん性肺疾患. 黒崎喜久, 編. 単純X線写真の読み方・使い方. 東京 : 医学書院, 2013 : 144-50.
8) 審良正則. VII-10. 肉芽腫性疾患 c. 過敏性肺炎. 村田喜代史, 上甲剛, 村山貞之, 編. 胸部のCT (第3版). 東京 : メディカル・サイエンス・インターナショナル, 2011 : 528-33.
9) 加藤勝也, 市村浩一. 6章 吸入性疾患 過敏性肺炎 (急性, 亜急性). 芦澤和人, 編. 病理像との対比と参考症例に学ぶ胸部の画像診断 1. 肺. 東京 : ベクトル・コア, 2011 : 160-1.
P.179 掲載の参考文献
1) Saltzstein SL. Pulmonary malignant lymphomas and pseudolymphomas : classification, therapy and prognosis. Cancer 1963 ; 16 : 928-55.
2) Koss MN, Hochholzer L, Nichols PW, et al. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung : a study of 161 patients. Hum Pathol 1983 ; 14 : 1024-38.
3) Cadranel J, Wislez M, Antonie M. Primaly pulmonary lymphoma. Eur Resir J 2002 ; 20 : 750-62.
4) Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983 ; 52 : 1410-6.
5) Bae YA, Lee KS, Han J, et al. Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue : imaging findings in 21 patients. Chest 2008 ; 133 : 433-40.
6) King KJ, Padley SP, Wotherspoon AC, et al. Pulmonary MALT lymphoma : imaging findings in 24 cases. Eur Radiol 2000 ; 10 : 1932-8.
7) Kinsely BL, Mastey LA, Mergo PJ, et al. Pulmonary mucosa-associated lymphoid tissue lymphoma : CT and pathologic findings. AJR Am J Roentgenol 1999 ; 172 : 1321-6.
8) Wislez M, Cadranel J, Antoine M, et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue : CT scan findings and pathological correlations. Eur Respir J 1999 ; 14 : 423-9.
9) 横井豊治, 中村栄男. 肺のMALTリンパ腫 (BALTリンパ腫). 病理と臨 1999 ; 17 : 154-60.
10) Sato H, Okada F, Mori T, et al. High-resolution computer tomography findings in patients with pulmonary nocardiosis. Acad Radiol 2016 ; 23 : 290-6.
11) Lewis ER, Caskey CI, Fishman EK. Lymphoma of the lung : CT findings in 31 patients. AJR Am J Roentgenol 1991 ; 156 : 711-4.
12) Pfleger L, Tappeiner J. Zur Kenntnis der systemisierten Endotheliomatose der cutanen Blutgefaβe (Reticuloendotheliose?). Hautarzt 1959 ; 10 : 359-63.
13) Colby TV. Malignancies in the lung and pleura mimicking benign process. Semin Diagn Pathol 1995 ; 12 : 30-44.
14) Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma : clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 2000 ; 111 : 826-34.
15) Walls JG, Hong YG, Cox JE, et al. Pulmonary intravascular lymphomatosis : presentation with dyspnea and air trapping. Chest 1999 ; 115 : 1207-10.
16) Cha MJ, Lee KS, Hwang HS, et al. Pulmonary intravascular lymphomatosis : clinical, CT, and PET findings, correlation of CT and pathologic results, and survival outcome. Radiology 2016 ; 280 : 602-10.
17) Okada F, Ando Y, Yoshitake S, et al. Clinical/pathologic correlations in 553 patients with primary centrilobular findings on high-resolution CT scan of the thorax. Chest 2007 ; 132 : 1939-48.
18) Okada F, Ando Y, Yoshitake S, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology 2006 ; 240 : 559-64.
19) Okada F, Ando Y, Kondo Y, et al. Thoracic CT findings of adult T-cell leukemia or lymphoma. AJR Am J Roentgenol 2004 ; 182 : 761-7.
20) Okada F, Sato H, Omeri AK, et al. Chest HRCT findings in acute transformation of adult T-cell lymphoma/leukemia. Eur Radiol 2015 ; 25 : 1607-13.
21) Klimiuk PA, Fiedorczyk M, Sierakowski S, et al. Soluble cell adhesion molecules (sICAM-1 sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand J Rheumatol 2007 ; 36 : 345-50.
22) Tokuyama K, Okada F, Matsumoto S, et al. EBVpositive MTX-diffuse large B cell lymphoma in a rheumatoid arthritis patient. Jpn J Radiol 2014 ; 32 : 183-7.
23) Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016 ; 127 : 2375-90.
24) Tokuyama K, Okada F, Sato H, et al. Computed tomography findings in Epstein-Barr virus (EBV) -positive diffuse large B-cell lymphoma (DLBCL) of the elderly : comparison with EBV-negative DLBCL. Br J Radiol 2017 ; 90 : 20160879.
P.189 掲載の参考文献
1) Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012 ; 366 : 539-51.
2) 岡崎和一, 川茂幸, 神澤輝実, ほか. IgG4関連疾患包括診断基準 2011. 日内会誌 2012 ; 101 : 795-804.
3) Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details. Mod Rheumatol 2012 ; 22 : 1-14.
4) 松井祥子. IgG4関連疾患. 日サ会誌 2015 ; 35 : 47-9.
5) Matsui S, Hebisawa A, Sakai F, et al. Immunoglobulin G4-related lung disease : clinicoradiological and pathological features. Respirology 2013 ; 18 : 480-7.
6) Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease : CT findings with pathologic correlations. Radiology 2009 ; 251 : 260-70.
7) 松井祥子, 山本洋, 源誠二郎, ほか. IgG4関連呼吸器疾患の診断基準. 日呼吸誌 2015 ; 4 : 129-32.
8) Fujita A, Sakai O, Chapman MN, et al. IgG4-related disease of the head and neck : CT and MR imaging manifestations. Radiographics 2012 ; 32 : 1945-58.
9) Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis : CT and MR characteristics. AJR Am J Roentgenol 1998 ; 170 : 1323-7.
10) 石坂幸雄, 本田茉也, 吉原桂一, ほか. IgG4関連疾患における顎下腺の超音波検査及びガイド下生検の検討. 超音波医 2016 ; 43 : S699.
11) Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972 ; 29 : 670-83.
12) Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 2005 ; 106 : 2627-32.
13) Terasaki Y, Ikushima S, Matsui S, et al. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease. Histopathology 2017 ; 70 : 1114-24.
14) Johkoh T, Muller NL, Ichikado K, et al. Intrathoracic multicentric Castleman disease : CT findings in 12 patients. Radiology 1998 ; 209 : 477-81.
15) Fazakas A, Csire M, Berencsi G, et al. Multicentric plasmocytic Castleman's disease with polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome and coexistent human herpes virus-6 infection-a possible relationship. Leuk Lymphoma 2009 ; 50 : 1661-5.
16) Dispenzieri A. POEMS syndrome. Blood Rev 2007 ; 21 : 285-99.
17) 高井和江, 新國公司, 渋谷宏行, ほか. 発熱, 胸腹水, 肝脾腫を伴い, 骨髄に軽度の線維化を認める血小板減少症. 臨血 2010 ; 51 : 320-5.
18) Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 2016 ; 91 : 220-6.
P.196 掲載の参考文献
1) Fraser RS, Muller NL, Colman N, et al. Secondary neoplasms. In : Fraser and Pare's diagnosis of diseases of the chest, 4th ed. Philadelphia : Saunders, 1999 : 1381-417.
2) Janower ML, Blennerhassett JB. Lymphangitic spread of metastatic cancer to the lung. A radiologic-pathologic classification. Radiology 1971 ; 101 : 261-73.
3) Munk PL, Muler NL, Miller RR, et al. Pulmonary lymphangitic carcinomatosis : CT and pathologic findings. Radiology 1988 ; 166 : 705-9.
4) Muller NL, Fraser RS, Lee KS, et al. Miscellaneous neoplasms. In : Disease of the lung : radiological and pathologic correlations. Philadelphia : Lippincott Williams & Wilkins, 2003 : 117-35.
5) Johkoh T, Ikezoe J, Tomiyama N, et al. CT findings in lymphangitic carcinomatosis of the lung : correlation with histologic findings and pulmonary function tests. AJR Am J Roentgenol 1992 ; 158 : 1217-22.
6) Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumors, 8th ed. New Jersey : John Wiley & Sons, 2017.
7) 日本肺癌学会, 編. 肺癌取扱い規約 (第8版). 東京 : 金原出版, 2017.
8) von Herbay A, Illes A, Waldherr R, et al. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990 ; 66 : 587-92.
9) Franquet T, Gimenez A, Prats R, et al. Thrombotic microangiopathy of pulmonary tumors : a vascular cause of tree-in-bud pattern on CT. AJR Am J Roentgenol 2002 ; 179 : 897-9.
10) Han D, Lee KS, Franquet T, et al. Thrombotic and nonthrombotic pulmonary arterial embolism : spectrum of imaging findings. Radiographics 2003 ; 23 : 1521-39.
P.202 掲載の参考文献
2) McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011 ; 364 : 1595-606.
3) Takada T, Mikami A, Kitamura N, et al. Efficacy and safety of long-term sirolimus therapy for Asian patients with lymphangioleiomyomatosis. Ann Am Thorac Soc 2016 ; 13 : 1912-22.
4) 久保惠嗣, 井上義一. 本邦におけるLAMの治療, 予後の現状と問題点. 日胸 2006 ; 65 : 150-5.
5) 林田美江, 藤本圭作, 久保惠嗣, ほか. わが国におけるLAMの疫学. 日胸 2006 ; 65 : 113-9.
6) Oprescu N, McCormack FX, Byrnes S, et al. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis : a population-based registry. Lung 2013 ; 191 : 35-42.
7) Wataya-Kaneda M, Tanaka M, Hamasaki T, et al. Trends in the prevalence of tuberous sclerosis complex manifestations : an epidemiological study of 166 Japanese patients. PLoS One 2013 ; 8 : e63910.
8) Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001 ; 164 : 669-71.
9) Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 2001 ; 164 : 661-8.
10) Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000 ; 75 : 591-4.
11) Muller NL, Chiles C, Kullnig P. Pulmonary lymphangiomyomatosis : correlation of CT with radiographic and functional findings. Radiology 1990 ; 175 : 335-9.
12) Tobino K, Johkoh T, Fujimoto K, et al. Computed tomographic features of lymphangioleiomyomatosis : evaluation in 138 patients. Eur J Radiol 2015 ; 84 : 534-41.
13) Lee KN, Yoon SK, Choi SJ, et al. Cystic lung disease : a comparison of cystic size, as seen on expiratory and inspiratory HRCT scans. Korean J Radiol 2000 ; 1 : 84-90.
14) Worthy SA, Brown MJ, Muller NL. Technical report : cystic air spaces in the lung : change in size on expiratory high-resolution CT in 23 patients. Clin Radiol 1998 ; 53 : 515-9.
15) Crausman RS, Lynch DA, Mortenson RL, et al. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis. Chest 1996 ; 109 : 131-7.
16) Avila NA, Kelly JA, Dwyer AJ, et al. Lymphangioleiomyomatosis : correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis. Radiology 2002 ; 223 : 189-97.
17) Corrin B, Liebow AA, Friedman PJ. Pulmonary lymphangiomyomatosis. A review. Am J Pathol 1975 ; 79 : 348-82.
18) Maruyama H, Seyama K, Sobajima J, et al. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene. Mod Pathol 2001 ; 14 : 609-14.
19) Popper HH, Juettner-Smolle FM, Pongratz MG. Micronodular hyperplasia of type II pneumocytes : a new lung lesion associated with tuberous sclerosis. Histopathology 1991 ; 18 : 347-54.
20) Lantuejoul S, Ferretti G, Negoescu A, et al. Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis. Histopathology 1997 ; 30 : 570-5.
21) Muir TE, Leslie KO, Popper H, et al. Micronodular pneumocyte hyperplasia. Am J Surg Pathol 1998 ; 22 : 465-72.
22) Aughenbaugh GL. Thoracic manifestations of neurocutaneous diseases. Radiol Clin North Am 1984 ; 22 : 741-56.
23) Pui MH, Kong HL, Choo HF. Bone changes in tuberous sclerosis mimicking metastases. Australas Radiol 1996 ; 40 : 77-9.
24) Avila NA, Dwyer AJ, Rabel A, et al. Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis : comparison of CT features. Radiology 2007 ; 242 : 277-85.
P.207 掲載の参考文献
2) De la Torre C, Ocampo C, Doval IG, et al. Acrochordons are not a component of the Birt-Hogg-Dube syndrome : does this syndrome exist? Case reports and review of the literature. Am J Dermatopathol 1999 ; 21 : 369-74.
4) Zbar B, Alvord WG, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomarkers Prev 2002 ; 11 : 393-400.
7) Painter JN, Tapanainen H, Somer M, et al. A 4-bp deletion in the Birt-Hogg-Dube gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am J Hum Genet 2005 ; 76 : 522-7.
8) 飛野和則, 熊坂利夫, 栗原正利, ほか. Birt-Hogg-Dube症候群. 呼吸 2013 ; 32 : 164-72.
10) Johannesma PC, Reinhard R, Kon Y, et al. Prevalence of Birt-Hogg-Dube syndrome in patients with apparently primary spontaneous pneumothorax. Eur Respir J 2015 ; 45 : 1191-4.
12) Kumasaka T, Hayashi T, Mitani K, et al. Characterization of pulmonary cysts in Birt-Hogg-Dube syndrome : histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients. Histopathology 2014 ; 65 : 100-10.
14) Tobino K, Hirai T, Johkoh T, et al. Differentiation between Birt-Hogg-Dube syndrome and lymphangioleiomyomatosis : quantitative analysis of pulmonary cysts on computed tomography of the chest in 66 females. Eur J Radiol 2012 ; 81 : 1340-6.
P.215 掲載の参考文献
1) Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958 ; 258 : 1123-43.
2) Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008 ; 177 : 752-62.
3) 北市正則, 笠井孝彦, 寺本友昭, ほか. 肺胞蛋白症の病理所見. 日胸 2016 ; 75 : 1245-53.
4) Preger L. Pulmonary alveolar proteinosis. Radiology 1969 ; 92 : 1291-5.
5) Prakash UB, Barham SS, Carpenter HA, et al. Pulmonary alveolar phospholipoproteinosis : experience with 34 cases and a review. Mayo Clin Proc 1987 ; 62 : 499-518.
6) Ramirez RJ. Pulmonary alveolar proteinosis : a roentgenologic analysis. Am J Roentgenol Radium Ther Nucl Med 1964 ; 92 : 571-7.
7) Murch CR, Carr DH. Computed tomography appearance of pulmonary alveolar proteinosis. Clin Radiol 1989 ; 40 : 240-3.
8) Ishii H, Trapnell BC, Tazawa R, et al. Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest 2009 ; 136 : 1348-55.
9) Akira M, Inoue Y, Arai T, et al. Pulmonary fibrosis on high-resolution CT of patients with pulmonary alveolar proteinosis. Am J Roentgenol 2016 ; 207 : 544-51.
10) Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999 ; 190 : 875-80.
11) Holbert JM, Costello P, Li W, et al. CT features of pulmonary alveolar proteinosis. AJR Am J Roentgenol 2001 ; 176 : 1287-94.
12) Miller PA, Ravin CE, Smith GJ, et al. Pulmonary alveolar proteinosis with interstitial involvement. AJR Am J Roentgenol 1981 ; 137 : 1069-71.
13) Kang FY, Grenier P, Laurent F, et al. Interlobular septal thickening : patterns at high-resolution computed tomography. J Thorac Imaging 1996 ; 11 : 260-4.
14) Handa T, Nakatsue T, Baba M, et al. Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behcet's disease. Respir Investig 2014 ; 52 : 75-9.
15) Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis : progress in the first 44 years. Am J Respir Crit Care Med 2002 ; 166 : 215-35.
16) Pascual J, Gomez Aguinaga MA, Vidal R, et al. Alveolar proteinosis and nocardiosis : a patient treated by bronchopulmonary lavage. Postgrad Med J 1989 ; 65 : 674-7.
17) Witty LA, Tapson VF, Piantadosi CA. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis. Medicine (Baltimore) 1994 ; 73 : 103-9.
18) 松久隆之, 森俊之, 浦田淳夫, ほか. アスペルギローマの合併により悪化した肺胞蛋白症の1例. 気管支学 2005 ; 27 : 372-7.
19) Frazier AA, Franks TJ, Cooke EO, et al. From the archives of AFIP : pulmonary alveolar proteinosis. Radiographics 2008 ; 28 : 883-99.
20) Arbiser ZK, Guidot DM, Pine JR, et al. Pulmonary alveolar proteinosis mimicking idiopathic pulmonary fibrosis. Ann Diag Pathl 2003 ; 7 : 82-6.
21) Lee KN, Levin DL, Webb WR, et al. Pulmonary alveolar proteinosis : high-resolution CT, chest radiographic, and functional correlations. Chest 1997 ; 111 : 989-95.
22) Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis : predicting response to therapy and survival. Am J Respir Crit Care Med 1998 ; 157 : 1063-72.
23) Akira M, Inoue G, Yamamoto S, et al. Non-specific interstitial pneumonia : findings on sequential CT scans of nine patients. Thorax 2000 ; 55 : 854-9.
24) Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2010 ; 181 : 1345-54.
25) Tokura S, Akira M, Okuma T, et al. A semiquantitative computed tomographic grading system for evaluating therapeutic response in pulmonary alveolar proteinosis. Ann Am Thorac Soc 2017 ; 14 : 1403-11.
26) Sverzellati N, Calabro E, Chetta A, et al. Vosial score and quantitative CT indices in pulmonary fibrosis : relationship with physiologic impairment. Radiol Med 2007 ; 112 : 1160-72.
27) Robinson TE, Trapnell BC, Goris ML, et al. Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis. Chest 2009 ; 135 : 842-8.
P.222 掲載の参考文献
1) Czeyda-Pommersheim F, Hwang M, Chen SS, et al. Amyloidosis : modern cross-sectional imaging. Radiographics 2015 ; 35 : 1381-92.
2) Webb WR, Muller NL, Naidich DP. Miscellaneous infiltrative lung diseases. In : High-resolution CT of the lung, 5th ed. Philadelphia : Wolters Kluwer Health, 2015 : 411-28.
3) Katzenstein AA. Amyloidosis. In : Katzenstein and Askin's surgical pathology of non-neoplastic lung diseases, 4th ed. Philadelphia : Saunders, 2006 : 194-6.
4) Graham CM, Stern EJ, Finkbeiner WE, et al. Highresolution CT appearance of diffuse alveolar septal amyloidosis. AJR Am J Roentgenol 1992 ; 158 : 265-7.
5) Kurahara Y, Tachibana K, Kitaichi M, et al. Pulmonary diffuse alveolar septal amyloidosis. Intern Med 2012 ; 51 : 1447-8.
6) Egashira R, Kondo T, Hirai T, et al. CT findings of thoracic manifestations of primary Sjogren syndrome : radiologic-pathologic correlation. Radiographics 2013 ; 33 : 1933-49.
7) Webb WR. Sarcoidosis. In : Webb WR, Higgins CB, editors. Thoracic imaging. Philadelphia : Lippincott Williams & Wilkins, 2005 : 439-49.
8) Akira M, Higashihara T, Yokoyama K, et al. Radiographic type p pneumoconiosis : high-resolution CT. Radiology 1989 ; 171 : 117-23.
9) 荒川浩明. 珪肺症, mixed dust pneumoconiosis (MDP). 画像診断 2003 ; 23 : 10-9.
10) 本多修. 癌性リンパ管症. 高橋雅士, 上甲剛, 高橋康二, ほか, 編. 胸部画像診断スタンダード. 東京 : メディカル・サイエンス・インターナショナル, 2013 : 28-9.
11) Honda O, Johkoh T, Ichikado K, et al. Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma : is there any difference of involved interstitium? J Comput Assist Tomogr 1999 ; 23 : 374-9.
12) Saitoh U, Ohnishi-Amemiya A, Asano M, et al. Unique radiological features of two cases of primary pulmonary diffuse large B-cell lymphoma. Thorax 2017 ; 72 : 859-60.
13) Rho L, Qiu L, Strauchen JA, et al. Pulmonary manifestations of light chain deposition disease. Respirology 2009 ; 14 : 767-70.
P.227 掲載の参考文献
1) Caffrey PR, Altman RS. Pulmonary alveolar microlitbiasis occurring in premature twins. J Pediatr 1965 ; 66 : 758-63.
2) Chu A, Shaharyar S, Chokshi B, et al. Pulmonary alveolar microlithiasis "stone lungs" : a case of clinico-radiological dissociation. Cureus 2016 ; 8 : e749.
3) Castellana G, Castellana G, Gentile M, et al. Pulmonary alveolar microlithiasis : review of the 1022 cases reported worldwide. Eur Respir Rev 2015 ; 24 : 607-20.
4) Huqun, Izumi S, Miyazawa H, et al. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 2007 ; 175 : 263-8.
5) Corut A, Senyigit A, Ugur SA, et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 2006 ; 79 : 650-6.
6) Saito A, Nikolaidis NM, Amlal H, et al. Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment. Sci Transl Med 2015 ; 7 : 313ra181.
7) Wang H, Yin X, Wu D, et al. SLC34A2 gene compound heterozygous mutation identification in a patient with pulmonary alveolar microlithiasis and computational 3D protein structure prediction. Meta Gene 2014 ; 2 : 557-64.
8) Sigari N, Nikkhoo B. First presentation of a case of pulmonary alveolar microlithiasis with spontaneous pneumothorax. Oman Med J 2014 ; 29 : 450-3.
9) Fallahi B, Ghafary BM, Fard-Esfahani A, et al. Diffuse pulmonary uptake of bone-seeking radiotracer in bone scintigraphy of a rare case of pulmonary alveolar microlithiasis. Indian J Nucl Med 2015 ; 30 : 277-9.
10) Sahoo MK, Karunanithi S, Bal CS. Pulmonary alveolar microlithiasis : imaging characteristics of planar and SPECT/CT bone scan versus 18 F-FDG and 18F-sodium fluoride PET/CT scanning. Jpn J Radiol 2013 ; 31 : 766-9.
11) Basu S, Shah M, Joshi JM, et al. Imaging calcific concretions of pulmonary alveolar microlithiasis with PET : insight into disease pathophysiology. Clin Nucl Med 2012 ; 37 : 707-8.
12) Gunay E, Ozcan A, Gunay S, et al. Pulmonary alveolar microlithiasis with low fluorodeoxyglucose accumulation in PET/computed tomography. Ann Thorac Med 2011 ; 6 : 237-40.
13) Klikovits T, Slama A, Hoetzenecker K, et al. A rare indication for lung transplantation-pulmonary alveolar microlithiasis : institutional experience of five consecutive cases. Clin Transplant 2016 ; 30 : 429-34.
P.235 掲載の参考文献
1) Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
2) 難治性血管炎に関する調査研究班. 顕微鏡的多発血管炎 (指定難病 43). 難病情報センターホームページ. URL : http://www.nanbyou.or.jp/entry/86 (情報更新日 2015/1/26)
3) JCS Joint Working Group. Guideline for management of vasculitis syndrome (JCS 2008). Japanese Cirulation Society. Circ J 2011 ; 75 : 474-503.
5) Ozaki S, Atsumi T, Hayashi T, et al. Severity-based treatment for Japanese patients with MPO-ANCAassociated vasculitis : the JMAAV study. Mod Rheumatol 2012 ; 22 : 394-404.
6) Sada KE, Yamamura M, Harigai M, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 2014 ; 16 : R101.
7) Yamagata M, Ikeda K, Tsushima K, et al. Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis : a multicenter, longitudinal, retrospective study of one hundred fifty consecutive hospital-based Japanese patients. Arthritis Rheumatol 2016 ; 68 : 713-23.
8) Hervier B, Pagnoux C, Agard C, et al. Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis 2009 ; 68 : 404-7.
9) Tzelepis GE, Kokosi M, Tzioufas A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010 ; 36 : 116-21.
10) Gocho K, Sugino K, Sato K, et al. Microscopic polyangiitis preceded by combined pulmonary fibrosis and emphysema. Respir Med Case Rep 2015 ; 15 : 128-32.
P.243 掲載の参考文献
1) Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
2) Fujimoto S, Watts RA, Kobayashi S, et al. Conparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U. K. Rheumatology 2011 ; 50 : 1916-20.
3) 厚生労働科学研究費補助金難治性疾患等政策研究事業, 編. ANCA関連血管炎診療ガイドライン 2017. 東京 : 診断と治療社, 2017.
4) Lee KS, Kim TS, Fujimoto K, et al. Thoracic manifestation of Wegener's granulomatosis : CT findings in 30 patients. Eur Radiol 2003 ; 13 : 43-51.
5) Cordier JF, Valeyre D, Guillevin L, et al. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest 1990 ; 97 : 906-12.
6) Usui Y, Suzuki A, Sakamoto S, et al. Pulmonary manifestations of granulomatosis with polyangiitis on HRCT. Rheumatology 2017 ; 56 : iii142.
7) Kuhlman JE, Hruban RH, Fishman EK. Wegener granulomatosis : CT features of parenchymal lung disease. J Comput Assist Tomogr 1991 ; 15 : 948-52.
8) Reuter M, Schnabel A, Wesner F, et al. Pulmonary Wegener's granulomatosis : correlation between highresolution CT findings and clinical scoring of disease activity. Chest 1998 ; 114 : 500-6.
9) Bicknell SG, Mason AC. Wegener's granulomatosis presenting as cryptogenic fibrosing alveolitis on CT. Clin Radiol 2000 ; 55 : 890-1.
10) Prince JS, Duhamel DR, Levin DL, et al. Nonneoplastic lesions of the tracheobronchial wall : radiologic findings with bronchoscopic correlation. Radiographics 2002 ; 22 ; S215-30.
11) 山村昌弘. 多発血管炎性肉芽腫症 (旧Wegener肉芽腫症). リウマチ科 2013 ; 50 : 441-9.
12) 有村義宏. 特集アレルギー疾患の診療のpitfalls. 好酸球の臨床 好酸球性多発血管炎性肉芽腫症. 診断と治療 2015 ; 103 : 649-54.
13) Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) : clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013 ; 65 : 270-81.
14) Vaglio A, Buzio C, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) : state of the art. Allergy 2013 ; 68 : 261-73.
15) Silva CIS, Muller NL, Fujimoto K, et al. Churg-Strauss syndrome : high resolution CT and pathologic findings. J Thoracic Imaging 2005 ; 20 : 74-80.
16) Suzuki A, Sakamoto S, Kurosaki A, et al. Pulmonary manifestations of eosinophilic granulomatosis with polyangiitis on HRCT. Rheumatology 2017 ; 56 : iii143.
17) Chusid MJ, Dale DC, West BC, et al. The hypereosinophilic syndrome : analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975 ; 54 : 1-27.
P.250 掲載の参考文献
1) Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004 ; 350 : 2487-98.
2) Stringer JR, Beard CB, Miller RF, et al. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002 ; 8 : 891-6.
3) Morris A, Lundgren JD, Masur H, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004 ; 10 : 1713-20.
4) Fujii T, Nakamura T, Iwamoto A. Pneumocystis pneumonia in patients with HIV infection : clinical manifestations, laboratory findings, and radiological features. J Infect Chemother 2007 ; 13 : 1-7.
5) Raoof S, Raoof S, Naidich DP. Imaging of unusual diffuse lung diseases. Curr Opin Pulm Med 2004 ; 10 : 383-9.
6) Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis 1990 ; 141 : 1356-72.
7) Limper AH, Offord KP, Smith TF, et al. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989 ; 140 : 1204-9.
8) Richards PJ, Riddell L, Reznek RH, et al. High resolution computed tomography in HIV patients with suspected Pneumocystis carinii pneumonia and a normal chest radiograph. Clin Radiol 1996 ; 51 : 689-93.
9) Hidalgo A, Falco V, Mauleon S, et al. Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients. Eur Radiol 2003 ; 13 : 1179-84.
10) Marchiori E, Muller NL, Soares Souza A Jr, et al. Pulmonary disease in patients with AIDS : high-resolution CT and pathologic findings. AJR Am J Roentgenol 2005 ; 184 : 757-64.
11) DeLorenzo LJ, Huang CT, Maguire GP, et al. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 1987 ; 91 : 323-7.
12) Naidich DP, Garay SM, Leitman BS, et al. Radiographic manifestations of pulmonary disease in the acquired immunodeficiency syndrome (AIDS). Semin Roentgenol 1987 ; 22 : 14-30.
13) Goodman PC. Pneumocystis carinii pneumonia. J Thorac Imaging 1991 ; 6 : 16-21.
14) Boiselle PM, Crans CA Jr, Kaplan MA. The changing face of Pneumocystis carinii pneumonia in AIDS patients. AJR Am J Roentgenol 1999 ; 172 : 1301-9.
15) Bergin CJ, Wirth RL, Berry GJ, et al. Pneumocystis carinii pneumonia : CT and HRCT observations. J Comput Assist Tomogr 1990 ; 14 : 756-9.
16) Kuhlman JE, Kavuru M, Fishman EK, et al. Pneumocystis carinii pneumonia : spectrum of parenchymal CT findings. Radiology 1990 ; 175 : 711-4.
17) Rossi SE, Erasmus JJ, Volpacchio M, et al. "Crazypaving" pattern at thin-section CT of the lungs : radiologic-pathologic overview. Radiographics 2003 ; 23 : 1509-19.
18) McGuinness G, Gruden JF. Viral and Pneumocystis carinii infections of the lung in the immunocompromised host. J Thorac Imaging 1999 ; 14 : 25-36.
19) Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am J Surg Pathol 1990 ; 14 : 615-25.
20) Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990 ; 12 : S701-10.
21) de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol 2002 ; 25 : S1-12.
22) Ison MG, Fishman JA. Cytomegalovirus pneumonia in transplant recipients. Clin Chest Med 2005 ; 26 : 691-705, viii.
23) Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004 ; 170 : 22-48.
24) Franquet T, Lee KS, Muller NL. Thin-section CT findings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS. AJR Am J Roentgenol 2003 ; 181 : 1059-63.
25) Konoplev S, Champlin RE, Giralt S, et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant 2001 ; 27 : 877-81.
26) Coy DL, Ormazabal A, Godwin JD, et al. Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation. Radiographics 2005 ; 25 : 305-17 ; discussion 318.
27) Boeckh M, Geballe AP. Cytomegalovirus : pathogen, paradigm, and puzzle. J Clin Invest 2011 ; 121 : 1673-80.
28) Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med 1993 ; 329 : 1922-6.
29) Olliff JF, Williams MP. Radiological appearances of cytomegalovirus infections. Clin Radiol 1989 ; 40 : 463-7.
30) Aafedt BC, Halvorsen RA Jr, Tylen U, et al. Cytomegalovirus pneumonia : computed tomography findings. Can Assoc Radiol J 1990 ; 41 : 276-80.
31) Kang EY, Patz EF Jr, Muller NL. Cytomegalovirus pneumonia in transplant patients : CT findings. J Comput Assist Tomogr 1996 ; 20 : 295-9.
32) McGuinness G, Scholes JV, Garay SM, et al. Cytomegalovirus pneumonitis : spectrum of parenchymal CT findings with pathologic correlation in 21 AIDS patients. Radiology 1994 ; 192 : 451-9.
33) Franquet T, Muller NL, Gimenez A, et al. Infectious pulmonary nodules in immunocompromised patients : usefulness of computed tomography in predicting their etiology. J Comput Assist Tomogr 2003 ; 27 : 461-8.
34) Kremer JM, Alarcon GS, Weinblatt ME, et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis : a multicenter study with literature review. Arthritis Rheum 1997 ; 40 : 1829-37.
35) St Clair EW, Rice JR, Snyderman R. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch Intern Med 1985 ; 145 : 2035-8.
P.259 掲載の参考文献
1) Shiley KT, Van Deerlin VM, Miller WT Jr. Chest CT features of community-acquired respiratory viral infections in adult inpatients with lower respiratory tract infections. J Thorac Imaging 2010 ; 25 : 68-75.
2) Dolin R. Clinical manifestations of seasonal influenza in adults. UpToDate homepage. URL : http://www.uptodate.com/contents/clinical-manifestations-of-seasonal-influenza-in-adults (Accessed 26 August 2017)
3) Kloth C, Forler S, Gatidis S, et al. Comparison of chest-CT findings of Influenza virus-associated pneumonia in immunocompetent vs. immunocompromised patients. Eur J Radiol 2015 ; 84 : 1177-83.
4) Tanaka N, Emoto T, Suda H, et al. High-resolution computed tomography findings of influenza virus pneumonia : a comparative study between seasonal and novel (H1N1) influenza virus pneumonia. Jpn J Radiol 2012 ; 30 : 154-61.
5) Fujita J, Ohtsuki Y, Higa H, et al. Clinicopathological findings of four cases of pure influenza virus A pneumonia. Intern Med 2014 ; 53 : 1333-42.
6) Marchiori E, Zanetti G, D'Ippolito G, et al. Swine-origin influenza A (H1N1) viral infection : thoracic findings on CT. AJR Am J Roentgenol 2011 ; 196 : W723-8.
7) Li P, Su DJ, Zhang JF, et al. Pneumonia in novel swine-origin influenza A (H1N1) virus infection : highresolution CT findings. Eur J Radiol 2011 ; 80 : e146-52.
8) Ishiguro T, Takayanagi N, Kanauchi T, et al. Clinical and radiographic comparison of influenza virus-associated pneumonia among three viral subtypes. Intern Med 2016 ; 55 : 731-7.
9) Cornejo R, Llanos O, Fernandez C, et al. Organizing pneumonia in patients with severe respiratory failure due to novel A (H1N1) influenza. BMJ Case Rep 2010 ; 2010 : pii : bcr0220102708.
10) Torrego A, Pajares V, Mola A, et al. Influenza A (H1N1) organising pneumonia. BMJ Case Rep 2010 ; 2010 : pii bcr1220092531.
11) Marchiori E, Zanetti G, Fontes CA, et al. Influenza A (H1N1) virus-associated pneumonia : high-resolution computed tomography-pathologic correlation. Eur J Radiol 2011 ; 80 : e500-4.
12) Li P, Zhang JF, Xia XD, et al. Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection. Br J Radiol 2012 ; 85 : 729-35.
13) 石黒卓, 高柳昇, 清水禎彦, ほか. 抗体価と免疫組織化学的染色で診断した, びまん性肺胞傷害合併A型インフルエンザ肺炎の1例. 日呼吸会誌 2011 ; 49 : 942-8.
14) 藤井真央, 大西尚, 吉岡潤哉, ほか. 急性間質性肺炎としてステロイド, 免疫抑制剤治療を行ったA型インフルエンザ肺炎の1例. 日胸 ; 2016 ; 75 : 1390-7.
15) Mayer J, Lehners N, Egerer G, et al. CT-morphological characterization of respiratory syncytial virus (RSV) pneumonia in immune-compromised adults. RoFo 2014 ; 186 : 686-92.
16) Gasparetto EL, Escuissato DL, Marchiori E, et al. High-resolution CT findings of respiratory syncytial virus pneumonia after bone marrow transplantation. AJR Am J Roentgenol 2004 ; 182 : 1133-7.
17) Park CK, Kwon H, Park JY. Thin-section computed tomography findings in 104 immunocompetent patients with adenovirus pneumonia. Acta radiol 2017 ; 58 : 937-43.
18) Gotway MB. Pulmonary Infections. In : Webb WR, Higgins CB, editors. Thoracic imaging : pulmonary and cardiovascular radiology, 3rd ed. Philadelphia : Wolters Kluwer, 2016 : 400-54.
19) Tan D, Fu Y, Xu J, et al. Severe adenovirus community-acquired pneumonia in immunocompetent adults : chest radiographic and CT findings. J Thorac Dis 2016 ; 8 : 848-54.
20) Frangides CY, Pneumatikos I. Varicella-zoster virus pneumonia in adults : report of 14 cases and review of the literature. Eur J Intern Med 2004 ; 15 : 364-70.
21) Kim JS, Ryu CW, Lee SI, et al. High-resolution CT findings of varicella-zoster pneumonia. AJR Am J Roentgenol 1999 ; 172 : 113-6.
22) Okada F, Ando Y, Yoshitake S, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology 2006 ; 240 : 559-64.
23) Yamashiro T, Kamiya H, Miyara T, et al. CT scans of the chest in carriers of human T-cell lymphotropic virus type 1 : presence of interstitial pneumonia. Acad Radiol 2012 ; 19 : 952-7.
P.269 掲載の参考文献
1) Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet 1967 ; 2 : 319-23.
2) 3学会合同ARDS診療ガイドライン2016作成委員会, 編. ARDS診療ガイドライン2016. 東京 : 日本呼吸器学会, 2016.
3) Kligerman SJ, Franks TJ, Galvin JR. From the radiologic pathology archives : organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics 2013 ; 33 : 1951-75.
4) Hudson LD, Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest 1999 ; 116 : 74S-82S.
5) Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994 ; 149 : 818-24.
6) ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome : the Berlin Definition. JAMA 2012 ; 307 : 2526-33.
7) Gluecker T, Capasso P, Schnyder P, et al. Clinical and radiologic features of pulmonary edema. Radiographics 1999 ; 19 : 1507-31.
8) American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002 ; 165 : 277-304.
9) Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007 ; 176 : 636-43.
11) Tagliabue M, Casella TC, Zincone GE, et al. CT and chest radiography in the evaluation of adult respiratory distress syndrome. Acta Radiol 1994 ; 35 : 230-4.
12) Sheard S, Rao P, Devaraj A. Imaging of acute respiratory distress syndrome. Respir Care 2012 ; 57 : 607-12.
13) Desai SR, Wells AU, Suntharalingam G, et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary injury : a comparative CT study. Radiology 2001 ; 218 : 689-93.
14) Ichikado K, Suga M, Muranaka H, et al. Prediction of prognosis for acute respiratory distress syndrome with thin-section CT : validation in 44 cases. Radiology 2006 ; 238 : 321-9.
15) Ichikado K, Muranaka H, Gushima Y, et al. Fibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency : a prospective observational cohort study. BMJ Open 2012 ; 2 : e000545.
16) Desai SR, Wells AU, Rubens MB, et al. Acute respiratory distress syndrome : CT abnormalities at longterm follow-up. Radiology 1999 ; 210 : 29-35.
17) Masclans JR, Roca O, Munoz X, et al. Quality of life, pulmonary function, and tomographic scan abnormalities after ARDS. Chest 2011 ; 139 : 1340-6.
18) Fraser RS, Pare JAP, Fraser RG, et al. Pulmonary hypertension and edema. Synopsis of diseases of the chest, 2nd ed. Philadelphia : W. B. Saunders, 1994 : 574-621.
19) Webb WR, Muller NL, Naidich DP. Diffuse pulmonary hemorrhage, pulmonary edema, and acute respiratory syndrome. High-resolution CT of the lung, 4th ed. Philadelphia : Lipponcott Williams & Wilkins, 2009 : 462-78.
20) Nambu A, Ozawa K, Kobayashi N, et al. Imaging of community-acquired pneumonia : roles of imaging examinations, imaging diagnosis of specific pathogens and discrimination from noninfectious diseases. World J Radiol 2014 ; 6 : 779-93.
21) Silver SF, Muller NL, Miller RR, et al. Hypersensitivity pneumonitis : evaluation with CT. Radiology 1989 ; 173 : 441-5.
22) Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006 ; 27 : 142-7.
23) Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases : diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000 ; 216 : 773-80.
24) Akira M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997 ; 168 : 79-83.
26) Beasley MB, Franks TJ, Galvin JR, et al. Acute fibrinous and organizing pneumonia : a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002 ; 126 : 1064-70.
27) Lee KS, Kullnig P, Hartman TE, et al. Cryptogenic organizing pneumonia : CT findings in 43 patients. AJR Am J Roentgenol 1994 ; 162 : 543-6.
28) Ujita M, Renzoni EA, Veeraraghavan S, et al. Organizing pneumonia : perilobular pattern at thin-section CT. Radiology 2004 ; 232 : 757-61.
29) Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia : diagnostic implications. AJR Am J Roentgenol 2003 ; 180 : 1251-4.
30) Patel SR, Karmpaliotis D, Ayas NT, et al. The role of open-lung biopsy in ARDS. Chest 2004 ; 125 : 197-202.
P.277 掲載の参考文献
1) Anthony M, Singham S, Soans B, et al. Diffuse panbronchiolitis : not just an Asian disease : Australian case series and review of the literature. Biomed Imaging Interv J 2009 ; 5 : e19.
2) 吾妻安良太, 工藤翔二. びまん性汎細気管支炎. 日臨 2002 ; 60 : 32-45.
3) Chen Y, Kang J, Wu M, et al. Differential association between HLA and diffuse panbronchiolitis in Northern and Southern Chinese. Intern Med 2012 ; 51 : 271-6.
4) Kitaichi M, Nishimura K, Izumi T. Diffuse panbronchiolitis. In : Sharma OP, editor. Lung diseases in the tropics. New York : Marcel Dekker, 1991 : 479-509.
5) 中田紘一郎, 谷本普一. びまん性汎細気管支炎. 臨放 1981 ; 26 : 1133-42.
6) Reid L. The secondary lobule in the adult human lung, with special reference to its appearance in bronchograms. Thorax 1958 ; 13 : 110-5.
7) Rossi SE, Franquet T, Volpacchio M, et al. Tree-inbud pattern at thin-section CT of the lungs : radiologic-pathologic overview. Radiographics 2005 ; 25 : 789-801.
8) 西村浩一, 古江増裕, 北市正則, ほか. X線CT所見と剖検肺所見を対比検討できたびまん性汎細気管支炎の1例. 日胸 1987 ; 46 : 481-6.
9) Akira M, Kitatani F, Lee YS, et al. Diffuse panbronchiolitis : evaluation with high-resolution CT. Radiology 1988 ; 168 : 433-8.
10) Akira M, Higashihara T, Sakatani M, et al. Diffuse panbronchiolitis : follow-up CT examination. Radiology 1993 ; 189 : 559-62.
11) Yamada G, Igarashi T, Itoh E, et al. Centrilobular nodules correlate with air trapping in diffuse panbronchiolitis during erythromycin therapy. Chest 2001 ; 120 : 198-202.
12) Pipavath SJ, Lynch DA, Cool C, et al. Radiologic and pathologic features of bronchiolitis. AJR Am J Roentgenol 2005 ; 185 : 354-63.
13) Hu X, Yi ES, Ryu JH. Diffuse aspiration bronchiolitis : analysis of 20 consecutive patients. J Bras Pneumol 2015 ; 41 : 161-6.
14) Homma S, Kawabata M, Kishi K, et al. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J 1998 ; 12 : 444-52.
15) Hayakawa H, Sato A, Imokawa S, et al. Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease : similarities and differences. Intern Med 1998 ; 37 : 504-8.
16) Kadota J, Mukae H, Fujii T, et al. Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest 2004 ; 125 : 1239-47.
17) Cordier JF, Cottin V, Khouatra C, et al. Hypereosinophilic obliterative bronchiolitis : a distinct, unrecognised syndrome. Eur Respir J 2013 ; 41 : 1126-34.
P.282 掲載の参考文献
1) Kim CK, Kim SW, Kim JS, et al. Bronchiolitis obliterans in the 1990 s in Korea and the United States. Chest 2001 ; 120 : 1101-6.
2) 蛇澤晶, 朝川勝明, 杉野圭史, ほか. 閉塞性細気管支炎の病理. 呼吸 2008 ; 27 : 265-74.
3) Sugino K, Hebisawa A, Uekusa T, et al. Histopathological bronchial reconstruction of human bronchiolitis obliterans. Pathol Int 2011 ; 61 : 192-201.
4) Holland SA, Hutton LC, McKenzie FN. Radiologic findings in heart-lung transplantation : a preliminary experience. Can Assoc Radiol J 1989 ; 40 : 94-7.
5) Skeens JL, Fuhrman CR, Yousem SA. Bronchiolitis obliterans in heart-lung transplantation patients : radiologic findings in 11 patients. Am J Roentgenol 1989 ; 153 : 253-6.
6) Lau DM, Siegel MJ, Hildebolt CF, et al. Bronchiolitis obliterans syndrome : thin-section CT diagnosis of obstructive changes in infants and young children after lung transplantation. Radiology 1998 ; 208 : 783-8.
7) Jung JI, Jung WS, Hahn ST, et al. Bronchiolitis obliterans after allogenic bone marrow transplantation : HRCT findings. Korean J Radiol 2004 ; 5 : 107-13.
8) Worthy SA, Park CS, Kim JS, et al. Bronchiolitis obliterans after lung transplantation : high-resolution CT findings in 15 patients. Am J Roentgenol 1997 ; 169 : 673-7.
9) Ooi GC, Peh WC, Ip M. High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation. Respiration 1998 ; 65 : 187-91.
10) Leung AN, Fisher K, Valentine V, et al. Bronchiolitis obliterans after lung transplantation : detection using expiratory HRCT. Chest 1998 ; 113 : 365-70.
11) Gunn ML, Godwin JD, Kanne JP, et al. High-resolution CT finings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 2008 ; 23 : 244-50.
12) Yang CF, Wu MT, Chiang AA, et al. Correlation of high-resolution CT and pulmonary function in bronchiolitis obliterans : a study based on 24 patients associated with consumption of Sauropus androgynus. AJR Am J Roentgenol 1997 ; 168 : 1045-50.
13) Konen E, Gutierrez C, Chaparro C, et al. Bronchiolitis obliterans syndrome in lung transplant recipients : can thin-section CT findings predict disease before its clinical appearance? Radiology 2004 ; 231 : 467-73.
P.289 掲載の参考文献
1) 日本呼吸器学会COPD ガイドライン第4版作成委員会, 編. COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン (第4版). 東京 : 日本呼吸器学会, 2013.
2) Smith BM, Austin JH, Newell JD Jr, et al. Pulmonary emphysema subtypes on computed tomography : the MESA COPD study. Am J Med 2014 ; 127 : 94.e7-23.
3) Greene R. "Saber-sheath" trachea : relation to chronic obstructive pulmonary disease. AJR Am J Roentgenol 1978 ; 130 : 441-5.
4) Lynch DA, Austin JH, Hogg JC, et al. CT-definable subtypes of chronic obstructive pulmonary disease : a statement of the Fleischner Society. Radiology 2015 ; 277 : 192-205.
5) Matsuoka S, Kurihara Y, Yagihashi K, et al. Morphological progression of emphysema on thin-section CT : analysis of longitudinal change in the number and size of low-attenuation clusters. J Comput Assist Tomogr 2006 ; 30 : 669-74.
6) Seyama K, Hirai T, Mishima M, et al. A nationwide epidemiological survey of alpha1-antitrypsin deficiency in Japan. Respir Investig 2016 ; 54 : 201-6.
7) Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol 1982 ; 33 : 379-87.
8) Kim SS, Seo JB, Lee HY, et al. Chronic obstructive pulmonary disease : lobe-based visual assessment of volumetric CT by using standard images-comparison with quantitative CT and pulmonary function test in the COPDGene study. Radiology 2013 ; 266 : 626-35.
9) Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006 ; 173 : 1309-15.
10) Han MK, Bartholmai B, Liu LX, et al. Clinical significance of radiologic characterizations in COPD. COPD 2009 ; 6 : 459-67.
11) Remy-Jardin M, Edme JL, Boulenguez C, et al. Longitudinal follow-up study of smoker's lung with thinsection CT in correlation with pulmonary function tests. Radiology 2002 ; 222 : 261-70.
12) Eda S, Kubo K, Fujimoto K, et al. The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. Am J Respir Crit Care Med 1997 ; 155 : 1290-4.
13) Lee HJ, Seo JB, Chae EJ, et al. Tracheal morphology and collapse in COPD : correlation with CT indices and pulmonary function test. Eur J Radiol 2011 ; 80 : e531-5.
14) Washko GR, Lynch DA, Matsuoka S, et al. Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 2010 ; 17 : 48-53.
15) Tan RT, Kuzo R, Goodman LR, et al. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group. Chest 1998 ; 113 : 1250-6.
16) Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 2012 ; 367 : 913-21.
17) Matsuoka S, Washko GR, Yamashiro T, et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med 2010 ; 181 : 218-25.
18) Matsuoka S, Washko GR, Dransfield MT, et al. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD : correlations with emphysema and airflow limitation. Acad Radiol 2010 ; 17 : 93-9.
19) Wang Z, Chen X, Liu K, et al. Small pulmonary vascular alteration and acute exacerbations of COPD : quantitative computed tomography analysis. Int J Chron Obstruct Pulmon Dis 2016 ; 11 : 1965-71.
20) Martinez-Garcia MA, Soler-Cataluna JJ, Donat Sanz Y, et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011 ; 140 : 1130-7.
P.296 掲載の参考文献
1) Luqmani R, Hennell S, Estrach C, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology (Oxford) 2009 ; 48 : 436-9.
2) Bamji A, Cooke N. Rheumatoid arthritis and chronic bronchial suppuration. Scand J Rheumatol 1985 ; 14 : 15-21.
3) Shadick NA, Fanta CH, Weinblatt ME, et al. Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore) 1994 ; 73 : 161-70.
4) Ong HK, Lee AL, Hill CJ, et al. Effects of pulmonary rehabilitation in bronchiectasis : a retrospective study. Chron Respir Dis 2011 ; 8 : 21-30.
5) De Soyza A, McDonnell MJ, Goeminne PC, et al. Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis : a multicenter cohort study. Chest 2017 ; 151 : 1247-54.
6) Wilczynska MM, Condliffe AM, McKeon DJ. Coexistence of bronchiectasis and rheumatoid arthritis : revisited. Respir Care 2013 ; 58 : 694-701.
7) Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis : clinical, functional, and HRCT findings. Am J Respir Crit Care Med 1998 ; 157 : 1658-65.
8) Mohd Noor N, Mohd Shahrir MS, Shahid MS, et al. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. Int J Rheum Dis 2009 ; 12 : 136-44.
9) Wilsher M, Voight L, Milne D, et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med 2012 ; 106 : 1441-6.
10) Howling SJ, Hansell DM, Wells AU, et al. Follicular bronchiolitis : thin-section CT and histologic findings. Radiology 1999 ; 212 : 637-42.
11) 新田哲久, 田中伴典, 園田明永, ほか. 膠原病による気道病変. 画像診断 2016 ; 36 : 754-66.
12) Lynch JP 3rd, Weigt SS, DerHovanessian A, et al. Obliterative (constrictive) bronchiolitis. Semin Respir Crit Care Med 2012 ; 33 : 509-32.
13) Yam LY, Wong R. Bronchiolitis obliterans and rheumatoid arthritis. Report of a case in a Chinese patient on d-penicillamine and review of the literature. Ann Acad Med Singapore 1993 ; 22 : 365-8.
14) Hansell DM, Rubens MB, Padley SP, et al. Obliterative bronchiolitis : individual CT signs of small airways disease and functional correlation. Radiology 1997 ; 203 : 721-6.
15) Gunn ML, Godwin JD, Kanne JP, et al. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 2008 ; 23 : 244-50.
16) Hayakawa H, Sato A, Imokawa S, et al. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996 ; 154 : 1531-6.
17) Remy-Jardin M, Remy J, Cortet B, et al. Lung changes in rheumatoid arthritis : CT findings. Radiology 1994 ; 193 : 375-82.
18) Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease : CT patterns and their courses. J Comput Assist Tomogr 1999 ; 23 : 941-8.
19) Homma S, Kawabata M, Kishi K, et al. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J 1998 ; 12 : 444-52.
20) Hayakawa H, Sato A, Imokawa S, et al. Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease : similarities and differences. Intern Med 1998 ; 37 : 504-8.
21) Flament T, Bigot A, Chaigne B, et al. Pulmonary manifestations of Sjogren's syndrome. Eur Respir Rev 2016 ; 25 : 110-23.
22) Soto-Cardenas MJ, Perez-De-Lis M, Bove A, et al. Bronchiectasis in primary Sjogren's syndrome : prevalence and clinical significance. Clin Exp Rheumatol 2010 ; 28 : 647-53.
23) Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjogren's syndrome : a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005 ; 171 : 632-8.
24) Kreider M, Highland K. Pulmonary involvement in Sjogren syndrome. Semin Respir Crit Care Med 2014 ; 35 : 255-64.
P.305 掲載の参考文献
1) 日本呼吸器学会薬剤性肺障害の診断・治療の手引き作成委員会, 編. 薬剤性肺障害の診断・治療の手引き. 東京 : メディカルレビュー社, 2012.
2) 遠藤正浩, 新槇剛, 森口理久, ほか. 薬剤性肺障害の評価, 治療についてのガイドライン. 画像診断 2012 ; 32 : 794-805.
3) Ando M, Okamoto I, Yamamoto N, et al. Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 2006 ; 24 : 2549-56.
4) Kudoh S, Kato H, Nishiwaki Y, et al. Interstitial lung disease in Japanese patients with lung cancer : a cohort and nested case-control study. Am J Respir Crir Care Med 2008 ; 177 : 1348-57.
5) White DA, Camus P, Endo M, et al. Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma. Am J Respir Crit Care Med 2010 ; 182 : 396-403.
6) Nishino M, Chambers ES, Chong CR, et al. Anti-PD-1 inhibitor-related pneumonitis in non-small cell lung cancer. Cancer Immunol Res 2016 ; 4 : 289-93.
7) Nishino M, Ramaiya NH, Awad MM, et al. PD-1 inhibitor-related pneumonitis in advanced cancer patients : radiographic patterns and clinical course. Clin Cancer Res 2016 ; 22 : 6051-60.
8) Mamesaya N, Kenmotsu H, Katsumata M, et al. Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibody. Invest New Drugs 2017 ; 35 : 105-7.
9) Johkoh T, Sakai F, Kusumoto M, et al. Association between baseline pulmonary status and interstitial lung disease in patients with non-small-cell lung cancer treated with erlotinib : a cohort study. Clin Lung Cancer 2014 ; 15 : 448-54.
10) Camus P. Pneumotox on line : the drug-induced respiratory disease website. URL : http://www.pneumotox.com/
11) Camus P. Drug induced infiltrative lung disease. In : Schwarz MI, King TE Jr, editors. Interstitial lung disease, 4th ed. Hamilton : B. C. Decker, 2003 : 485-534.
12) Cleverley JR, Screaton NJ, Hiorns MP, et al. Druginduced lung disease : high-resolution CT and histological findings. Clin Radiol 2002 ; 57 : 292-9.
13) Akira M, lshikawa H, Yamamoto S. Drug-induced pneumonitis : thin-section CT findings in 60 patients. Radiology 2002 ; 224 : 852-60.
14) 酒井文和. 薬剤性肺障害の画像診断. 呼吸 2015 ; 34 : 32-8.
15) Endo M, Johkoh T, Kimura K, et al. Imaging of gefitinib-related interstitial lung disease : multi-institutional analysis by the West Japan Thoracic Oncology Group. Lung Cancer 2006 ; 52 : 135-40.
16) Sakai F, Johkoh T, Kusumoto M, et al. Druginduced interstitial lung disease in molecular targeted therapies : high-resolution CT findings. Int J Clin Oncol 2012 ; 17 : 542-50.
17) Sakai F, Noma S, Kurihara Y, et al. Leflunomiderelated lung injury in patients with rheumatoid arthritis : imaging features. Mod Rheumatol 2005 ; 15 : 173-9.
18) Arakawa H, Yamasaki M, Kurihara Y, et al. Methotrexate-induced pulmonary injury : serial CT findings. J Thorac Imaging 2003 ; 18 : 231-6.
19) Tamiya A, Endo M, Shukuya T, et al. Features of gemcitabine-related severe pulmonary toxicity : patients with pancreatic or biliary tract cancer. Pancreas 2009 ; 38 : 838-40.
20) Souza CA, Muller NL, Johkoh T, et al. Druginduced eosinophilic pneumonia : high-resolution CT findings in 14 patients. AJR Am J Roentgenol 2006 ; 186 : 368-73.

最近チェックした商品履歴

Loading...